drug_name,chembl_id,mechanism_of_actions,smiles
LOSARTAN POTASSIUM,CHEMBL995,Type-1 angiotensin II receptor antagonist,CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[n-]2)cc1.[K+]
CANDESARTAN CILEXETIL,CHEMBL1014,Type-1 angiotensin II receptor antagonist,CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1
TELMISARTAN,CHEMBL1017,Type-1 angiotensin II receptor antagonist,CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1
VALSARTAN,CHEMBL1069,Type-1 angiotensin II receptor antagonist,CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C
SPARSENTAN,CHEMBL539423,Type-1 angiotensin II receptor antagonist,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2S(=O)(=O)Nc2noc(C)c2C)c(COCC)c1
IRBESARTAN,CHEMBL1513,Type-1 angiotensin II receptor antagonist,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1
SARALASIN ACETATE,CHEMBL1200670,Type-1 angiotensin II receptor antagonist,CC(=O)O.CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C.O
OLMESARTAN MEDOXOMIL,CHEMBL1200692,Type-1 angiotensin II receptor antagonist,CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1
EPROSARTAN MESYLATE,CHEMBL1200987,Type-1 angiotensin II receptor antagonist,CCCCc1ncc(/C=C(\Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1.CS(=O)(=O)O
AZILSARTAN KAMEDOXOMIL,CHEMBL2103795,Type-1 angiotensin II receptor antagonist,CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[n-]2)cc1.[K+]
PRATOSARTAN,CHEMBL41194,Type-1 angiotensin II receptor antagonist,CCCc1nc2c(n1Cc1ccc(-c3ccccc3-c3nnn[nH]3)cc1)C(=O)CCCC2
AZILSARTAN,CHEMBL57242,Type-1 angiotensin II receptor antagonist,CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1
TASOSARTAN,CHEMBL432162,Type-1 angiotensin II receptor antagonist,Cc1nc(C)c2c(n1)N(Cc1ccc(-c3ccccc3-c3nnn[nH]3)cc1)C(=O)CC2
CANDESARTAN,CHEMBL1016,Type-1 angiotensin II receptor antagonist,CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1
CHOLECALCIFEROL,CHEMBL1042,Vitamin D receptor agonist,C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12
OLMESARTAN,CHEMBL1516,Type-1 angiotensin II receptor antagonist,CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1
ERGOCALCIFEROL,CHEMBL1536,Vitamin D receptor agonist,C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]12
FIMASARTAN,CHEMBL1951143,Type-1 angiotensin II receptor antagonist,CCCCc1nc(C)c(CC(=S)N(C)C)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1
TRV-120027,CHEMBL4297447,Type-1 angiotensin II receptor antagonist,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(=O)O
IRBESARTAN HYDROCHLORIDE,CHEMBL6068339,Type-1 angiotensin II receptor antagonist,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1.Cl
ILX23-7553,CHEMBL284121,Vitamin D receptor agonist,C=C1/C(=C\C=C2/CCC[C@]3(C)C([C@H](C)CC#CC(C)(C)O)=CC[C@@H]23)C[C@@H](O)C[C@@H]1O
CALCITRIOL,CHEMBL846,Vitamin D receptor agonist,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O
DP001,CHEMBL605525,Vitamin D receptor agonist,C=C1[C@H](O)CC(=C/C=C2\CCC[C@]3(C)[C@@H]([C@@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@H]1O
PARICALCITOL,CHEMBL1200622,Vitamin D receptor agonist,C[C@H](/C=C/[C@H](C)C(C)(C)O)[C@H]1CC[C@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@]12C
CALCIPOTRIENE,CHEMBL1200666,Vitamin D receptor agonist,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@@H](O)C4CC4)CC[C@@H]23)C[C@@H](O)C[C@@H]1O
DOXERCALCIFEROL,CHEMBL1200810,Vitamin D receptor agonist,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O
BECOCALCIDIOL,CHEMBL2104955,Vitamin D receptor agonist,C=C1[C@H](O)CC(=C/C=C2\CCC[C@]3(C)[C@@H]([C@@H](C)CC)CC[C@@H]23)C[C@H]1O
INECALCITOL,CHEMBL2105107,Vitamin D receptor agonist,C[C@H](CC#CC(C)(C)O)[C@H]1CC[C@@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@@]21C
LUNACALCIPOL,CHEMBL2105705,Vitamin D receptor agonist,C=C1/C(=C\C=C2/CCC[C@]3(C)C([C@H](C)C/C=C/S(=O)(=O)C(C)(C)C)=CC[C@@H]23)C[C@@H](O)C[C@@H]1O
CALCIFEDIOL,CHEMBL3544909,Vitamin D receptor agonist,C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]12.O
LOVASTATIN,CHEMBL503,HMG-CoA reductase inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21
CERIVASTATIN SODIUM,CHEMBL1200563,HMG-CoA reductase inhibitor,COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])c1-c1ccc(F)cc1.[Na+]
PITAVASTATIN CALCIUM,CHEMBL1237061,HMG-CoA reductase inhibitor,O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.[Ca+2]
ALFACALCIDOL,CHEMBL1601669,Vitamin D receptor agonist,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O
SEOCALCITOL,CHEMBL1908376,Vitamin D receptor agonist,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/C=C/C(O)(CC)CC)CC[C@@H]23)C[C@@H](O)C[C@@H]1O
FLUVASTATIN SODIUM,CHEMBL2218894,HMG-CoA reductase inhibitor,CC(C)n1c(/C=C/C(O)CC(O)CC(=O)[O-])c(-c2ccc(F)cc2)c2ccccc21.[Na+]
DIHYDROTACHYSTEROL,CHEMBL2356023,Vitamin D receptor agonist,CC(C)[C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3\C[C@@H](O)CC[C@@H]3C)CCC[C@]12C
ELOCALCITOL,CHEMBL3545094,Vitamin D receptor agonist,C=C1/C(=C\C=C2/CCC[C@]3(C)C([C@@H](C)C/C=C/C(O)(CC)CC)=CCC23)C[C@@H](O)C[C@@H]1O
PEFCALCITOL,CHEMBL3989862,Vitamin D receptor agonist,C=C1/C(=C\C=C2/CCC[C@]3(C)C([C@H](C)OCC(=O)NCC(F)(F)C(F)(F)F)=CC[C@@H]23)C[C@@H](O)C[C@@H]1O
ELDECALCITOL,CHEMBL4297608,Vitamin D receptor agonist,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)[C@@H](OCCCO)[C@@H]1O
PACLITAXEL,CHEMBL428647,Tubulin inhibitor,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
BIFONAZOLE,CHEMBL277535,HMG-CoA reductase inhibitor,c1ccc(-c2ccc(C(c3ccccc3)n3ccnc3)cc2)cc1
PRAVASTATIN SODIUM,CHEMBL690,HMG-CoA reductase inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@H]21.[Na+]
SIMVASTATIN,CHEMBL1064,HMG-CoA reductase inhibitor,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21
ATORVASTATIN CALCIUM,CHEMBL393220,HMG-CoA reductase inhibitor,CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].[Ca+2]
BRENTUXIMAB VEDOTIN,CHEMBL1742994,Tubulin inhibitor,
TRASTUZUMAB EMTANSINE,CHEMBL1743082,Tubulin inhibitor,
ROSUVASTATIN CALCIUM,CHEMBL1744447,HMG-CoA reductase inhibitor,CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-].[Ca+2]
PITAVASTATIN SODIUM,CHEMBL3989920,HMG-CoA reductase inhibitor,O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.[Na+]
PITAVASTATIN MAGNESIUM,CHEMBL3989923,HMG-CoA reductase inhibitor,O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.[Mg+2]
COLCHICINE,CHEMBL107,Tubulin inhibitor,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2
GRISEOFULVIN,CHEMBL562,Tubulin inhibitor,COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O
MEBENDAZOLE,CHEMBL685,Tubulin inhibitor,COC(=O)Nc1nc2cc(C(=O)c3ccccc3)ccc2[nH]1
VINBLASTINE SULFATE,CHEMBL378544,Tubulin inhibitor,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
VINCRISTINE SULFATE,CHEMBL501867,Tubulin inhibitor,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
VINORELBINE TARTRATE,CHEMBL538943,Tubulin inhibitor,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O
CABAZITAXEL,CHEMBL1201748,Tubulin inhibitor,CO[C@H]1C(=O)[C@]2(C)[C@@H](OC)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C
IXABEPILONE,CHEMBL1201752,Tubulin inhibitor,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)N1
ERIBULIN MESYLATE,CHEMBL1683544,Tubulin inhibitor,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C.CS(=O)(=O)O
DOCETAXEL,CHEMBL3545252,Tubulin inhibitor,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O
THIABENDAZOLE,CHEMBL625,Tubulin inhibitor,c1ccc2[nH]c(-c3cscn3)nc2c1
FOSBRETABULIN DISODIUM,CHEMBL289351,Tubulin inhibitor,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)([O-])[O-].[Na+].[Na+]
INDIBULIN,CHEMBL49642,Tubulin inhibitor,O=C(Nc1ccncc1)C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc12
ALBENDAZOLE,CHEMBL1483,Tubulin inhibitor,CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1
LEXIBULIN,CHEMBL552212,Tubulin inhibitor,CCC[C@H](Nc1nc(-c2ccc(NC(=O)NCC)c(OC)c2)ncc1C)c1cccnc1
PLINABULIN,CHEMBL1096380,Tubulin inhibitor,CC(C)(C)c1[nH]cnc1/C=c1\[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O
CROLIBULIN,CHEMBL2103852,Tubulin inhibitor,COc1cc([C@H]2C(C#N)=C(N)Oc3c2ccc(N)c3N)cc(Br)c1OC
VINFLUNINE,CHEMBL2110725,Tubulin inhibitor,CC[C@]12C=CCN3CC[C@@]4(c5cc([C@@]6(C(=O)OC)C[C@@H]7C[C@@H](C(C)(F)F)CN(Cc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32
POLATUZUMAB VEDOTIN,CHEMBL3301582,Tubulin inhibitor,
MIRVETUXIMAB SORAVTANSINE,CHEMBL3545132,Tubulin inhibitor,
TELISOTUZUMAB VEDOTIN,CHEMBL3990032,Tubulin inhibitor,
PF-06263507,CHEMBL4297804,Tubulin inhibitor,
TISOTUMAB VEDOTIN,CHEMBL4297841,Tubulin inhibitor,
AZINTUXIZUMAB VEDOTIN,CHEMBL4297859,Tubulin inhibitor,
RG-7841,CHEMBL4297935,Tubulin inhibitor,
LIFASTUZUMAB VEDOTIN,CHEMBL4297938,Tubulin inhibitor,
ENAPOTAMAB VEDOTIN,CHEMBL4297987,Tubulin inhibitor,
INDUSATUMAB VEDOTIN,CHEMBL4298045,Tubulin inhibitor,
LADIRATUZUMAB VEDOTIN,CHEMBL4298101,Tubulin inhibitor,
BELANTAMAB MAFODOTIN,CHEMBL4298209,Tubulin inhibitor,
DOLASTATIN-10,CHEMBL39541,Tubulin inhibitor,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)c1nccs1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C
ANG1005,CHEMBL1089636,Tubulin inhibitor,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](OC(=O)CCC(=O)NCCCC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](NC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]4C[C@@]5(O)[C@@H](OC(=O)c6ccccc6)[C@@H]6[C@]7(OC(C)=O)CO[C@@H]7C[C@H](O)[C@@]6(C)C(=O)[C@H](OC(C)=O)C(=C4C)C5(C)C)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCCCNC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]4C[C@@]5(O)[C@@H](OC(=O)c6ccccc6)[C@@H]6[C@]7(OC(C)=O)CO[C@@H]7C[C@H](O)[C@@]6(C)C(=O)[C@H](OC(C)=O)C(=C4C)C5(C)C)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)O)[C@@H](C)O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
GLEMBATUMUMAB VEDOTIN,CHEMBL1743028,Tubulin inhibitor,
RG-7600,CHEMBL2109281,Tubulin inhibitor,
RG-7636,CHEMBL2109282,Tubulin inhibitor,
ASG-5ME,CHEMBL2109574,Tubulin inhibitor,
PINATUZUMAB VEDOTIN,CHEMBL3301585,Tubulin inhibitor,
ENFORTUMAB VEDOTIN,CHEMBL3301589,Tubulin inhibitor,
TUSAMITAMAB RAVTANSINE,CHEMBL4298098,Tubulin inhibitor,
APRUTUMAB IXADOTIN,CHEMBL4650293,Tubulin inhibitor,
OXFENDAZOLE,CHEMBL42442,Tubulin inhibitor,COC(=O)Nc1nc2cc([S+]([O-])c3ccccc3)ccc2[nH]1
CANTUZUMAB MERTANSINE,CHEMBL1742997,Tubulin inhibitor,
LORVOTUZUMAB MERTANSINE,CHEMBL1743037,Tubulin inhibitor,
MILATAXEL,CHEMBL2107759,Tubulin inhibitor,CCC(=O)O[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)C2[C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](CC(=O)OC(C)(C)C)c4ccco4)C(C)=C([C@@H](O)C(=O)[C@@]21C)C3(C)C
BIVATUZUMAB MERTANSINE,CHEMBL2109288,Tubulin inhibitor,
TASIDOTIN,CHEMBL2111109,Tubulin inhibitor,CC(C)[C@H](NC(=O)[C@H](C(C)C)N(C)C)C(=O)N(C)[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NC(C)(C)C)C(C)C
SOFITUZUMAB VEDOTIN,CHEMBL3545372,Tubulin inhibitor,
VANDORTUZUMAB VEDOTIN,CHEMBL3833306,Tubulin inhibitor,
PRALUZATAMAB RAVTANSINE,CHEMBL4297736,Tubulin inhibitor,
ANVATABART OPADOTIN,CHEMBL4297892,Tubulin inhibitor,
OMBRABULIN,CHEMBL572284,Tubulin inhibitor,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)[C@@H](N)CO
CANTUZUMAB RAVTANSINE,CHEMBL1742998,Tubulin inhibitor,
VINFLUNINE DITARTRATE,CHEMBL2105629,Tubulin inhibitor,CC[C@]12C=CCN3CC[C@@]4(c5cc([C@@]6(C(=O)OC)C[C@@H]7C[C@@H](C(C)(F)F)CN(Cc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O
AVE-9633,CHEMBL2109266,Tubulin inhibitor,
COLTUXIMAB RAVTANSINE,CHEMBL2109286,Tubulin inhibitor,
MLN-2704,CHEMBL2109556,Tubulin inhibitor,
IMGN-388,CHEMBL2109633,Tubulin inhibitor,
SOBLIDOTIN,CHEMBL3989512,Tubulin inhibitor,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)NCCc1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C
PLOCABULIN,CHEMBL4297636,Tubulin inhibitor,C/C=C\C[C@@H](C/C=C\NC(=O)[C@@H](NC(=O)/C=C\C=C/C(C)=C/[C@H](C)[C@@H]1CC=C(OC)C(=O)O1)C(C)(C)C)OC(N)=O
LOSATUXIZUMAB VEDOTIN,CHEMBL4594515,Tubulin inhibitor,
INDATUXIMAB RAVTANSINE,CHEMBL1743031,Tubulin inhibitor,
VORSETUZUMAB MAFODOTIN,CHEMBL2108672,Tubulin inhibitor,
RG-7598,CHEMBL2109279,Tubulin inhibitor,
BIIB-015,CHEMBL2109575,Tubulin inhibitor,
ANETUMAB RAVTANSINE,CHEMBL2109629,Tubulin inhibitor,
SAR-566658,CHEMBL2109635,Tubulin inhibitor,
DENINTUZUMAB MAFODOTIN,CHEMBL3545371,Tubulin inhibitor,
DEPATUXIZUMAB MAFODOTIN,CHEMBL3707277,Tubulin inhibitor,
MECBOTAMAB VEDOTIN,CHEMBL5095312,Tubulin inhibitor,
TRASTUZUMAB BOTIDOTIN,CHEMBL5314782,Tubulin inhibitor,
BICALUTAMIDE,CHEMBL409,Androgen Receptor antagonist,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1
FLUTAMIDE,CHEMBL806,Androgen Receptor antagonist,CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1
APC-100,CHEMBL37676,Androgen Receptor antagonist,Cc1c(C)c2c(c(C)c1O)CCC(C)(C)O2
CYPROTERONE ACETATE,CHEMBL139835,Androgen Receptor antagonist,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C
NILUTAMIDE,CHEMBL1274,Androgen Receptor antagonist,CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O
ENZALUTAMIDE,CHEMBL1082407,Androgen Receptor antagonist,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F
GALETERONE,CHEMBL2105738,Androgen Receptor antagonist,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3cnc4ccccc43)=CC[C@@H]12
APALUTAMIDE,CHEMBL3183409,Androgen Receptor antagonist,CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F
CLASCOTERONE,CHEMBL3590187,Androgen Receptor antagonist,CCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C
DAROLUTAMIDE,CHEMBL4297185,Androgen Receptor antagonist,CC(O)c1cc(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1
AZD-7624,CHEMBL9960,MAP kinase p38 alpha inhibitor,CC[C@H](NC(=O)c1cc(-c2ccccc2)nc2ccccc12)c1ccccc1
ABIRATERONE,CHEMBL254328,Androgen Receptor antagonist,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3cccnc3)=CC[C@@H]12
AMG-548,CHEMBL585902,MAP kinase p38 alpha inhibitor,Cn1c(NC[C@@H](N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O
AZD-6703,CHEMBL2031465,MAP kinase p38 alpha inhibitor,Cc1ccc(C(=O)NC2CC2)cc1-n1cnc2ccc(N3CCN(C)CC3)cc2c1=O
SEVITERONEL,CHEMBL3264610,Androgen Receptor antagonist,CC(C)[C@](O)(c1ccc2cc(OC(F)F)c(OC(F)F)cc2c1)c1c[nH]nn1
AVE-9940,CHEMBL3545117,MAP kinase p38 alpha inhibitor,
PEXMETINIB,CHEMBL3991932,MAP kinase p38 alpha inhibitor,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1
PRUXELUTAMIDE,CHEMBL4594417,Androgen Receptor antagonist,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2F)C(=S)N1c1ccc(CCCc2ncco2)nc1
REZVILUTAMIDE,CHEMBL4650276,Androgen Receptor antagonist,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(OC[C@@H](O)CO)cc1
DORAMAPIMOD,CHEMBL103667,MAP kinase p38 alpha inhibitor,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1
RWJ-67657,CHEMBL190333,MAP kinase p38 alpha inhibitor | MAP kinase p38 beta inhibitor,OCCC#Cc1nc(-c2ccc(F)cc2)c(-c2ccncc2)n1CCCc1ccccc1
RO-3201195,CHEMBL203567,MAP kinase p38 alpha inhibitor,Nc1c(C(=O)c2cccc(OC[C@@H](O)CO)c2)cnn1-c1ccc(F)cc1
R-1487 HYDROCHLORIDE,CHEMBL1766582,MAP kinase p38 alpha inhibitor,Cl.Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21
PF-03715455,CHEMBL1938400,MAP kinase p38 alpha inhibitor,CC(C)(C)c1cc(NC(=O)NCc2ccccc2Sc2ccc3nnc(-c4ccccc4SCCO)n3c2)n(-c2ccc(O)c(Cl)c2)n1
GSK-610677,CHEMBL3544968,MAP kinase p38 alpha inhibitor,
LY-3007113,CHEMBL3544998,MAP kinase p38 alpha inhibitor,
LEO-15520,CHEMBL3545074,MAP kinase p38 alpha inhibitor,
PS-516895,CHEMBL3545139,MAP kinase p38 alpha inhibitor,
SB-85635,CHEMBL3545384,MAP kinase p38 alpha inhibitor,
ARRY-797,CHEMBL1088750,MAP kinase p38 alpha inhibitor,CC(C)Cn1ncc2cc(Oc3ccc(F)cc3F)c(C(=O)NCCN(C)C)cc21
SD-0006,CHEMBL1090173,MAP kinase p38 alpha inhibitor,O=C(CO)N1CCC(c2n[nH]c(-c3ccc(Cl)cc3)c2-c2ccncn2)CC1
BMS-582949,CHEMBL1230065,MAP kinase p38 alpha inhibitor,CCCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NC4CC4)ccc3C)c2c1C
SCIO-323,CHEMBL1614702,MAP kinase p38 alpha inhibitor,COc1cc2c(cc1C(=O)N1CCC(Cc3ccc(F)cc3)CC1)c(C(=O)C(=O)N(C)C)cn2C
DILMAPIMOD,CHEMBL2103838,MAP kinase p38 alpha inhibitor,Cc1cc(F)ccc1-c1nc(NC(CO)CO)nc2c1ccc(=O)n2-c1c(F)cccc1F
SEMAPIMOD,CHEMBL2107779,MAP kinase p38 alpha inhibitor,C/C(=N\NC(=N)N)c1cc(NC(=O)CCCCCCCCC(=O)Nc2cc(/C(C)=N/NC(=N)N)cc(/C(C)=N/NC(=N)N)c2)cc(/C(C)=N/NC(=N)N)c1
ITX-5061,CHEMBL3402567,MAP kinase p38 alpha inhibitor,COc1c(NC(=O)C(=O)c2ccc(OCCN3CCOCC3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O.Cl
SC-80036,CHEMBL3544930,MAP kinase p38 alpha inhibitor,
TA-5493,CHEMBL3545201,MAP kinase p38 alpha inhibitor,
FX-005,CHEMBL3545216,MAP kinase p38 alpha inhibitor,
NEFLAMAPIMOD,CHEMBL119385,MAP kinase p38 alpha inhibitor,O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl
TAK-715,CHEMBL363648,MAP kinase p38 alpha inhibitor,CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1
TALMAPIMOD,CHEMBL514201,MAP kinase p38 alpha inhibitor,C[C@@H]1CN(Cc2ccc(F)cc2)[C@@H](C)CN1C(=O)c1cc2c(C(=O)C(=O)N(C)C)cn(C)c2cc1Cl
PAMAPIMOD,CHEMBL1090089,MAP kinase p38 alpha inhibitor,Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC(CCO)CCO)nc21
VX-702,CHEMBL1090090,MAP kinase p38 alpha inhibitor,NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F
PH-797804,CHEMBL1088751,MAP kinase p38 alpha inhibitor,CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1
LOSMAPIMOD,CHEMBL1088752,MAP kinase p38 alpha inhibitor | MAP kinase p38 beta inhibitor,Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1
RALIMETINIB,CHEMBL2364626,MAP kinase p38 alpha inhibitor,CC(C)(C)Cn1c(N)nc2ccc(-c3[nH]c(C(C)(C)C)nc3-c3ccc(F)cc3)nc21
PG-760564,CHEMBL3545398,MAP kinase p38 alpha inhibitor,
ACUMAPIMOD,CHEMBL5314397,MAP kinase p38 alpha inhibitor,Cc1ccc(C(=O)NC2CC2)cc1-n1ncc(C(=O)c2cccc(C#N)c2)c1N
ACETAMINOPHEN,CHEMBL112,Anandamide amidohydrolase inhibitor | Cyclooxygenase inhibitor | Vanilloid receptor opener,CC(=O)Nc1ccc(O)cc1
NAPROXEN,CHEMBL154,Cyclooxygenase inhibitor,COc1ccc2cc([C@H](C)C(=O)O)ccc2c1
DICLOFENAC SODIUM,CHEMBL1034,Cyclooxygenase inhibitor,O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl.[Na+]
NAPROXEN SODIUM,CHEMBL1200806,Cyclooxygenase inhibitor,COc1ccc2cc([C@H](C)C(=O)[O-])ccc2c1.[Na+]
DICLOFENAC EPOLAMINE,CHEMBL1201180,Cyclooxygenase inhibitor,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl.OCCN1CCCC1
REDAFAMDASTAT,CHEMBL1651534,Anandamide amidohydrolase inhibitor,O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1
REGORAFENIB,CHEMBL1946170,MAP kinase p38 beta inhibitor,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1
FENOPROFEN CALCIUM,CHEMBL2103736,Cyclooxygenase inhibitor,CC(C(=O)[O-])c1cccc(Oc2ccccc2)c1.CC(C(=O)[O-])c1cccc(Oc2ccccc2)c1.O.O.[Ca+2]
IBUPROFEN SODIUM,CHEMBL3989408,Cyclooxygenase inhibitor,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.O.O.[Na+]
JNJ-42165279,CHEMBL4297294,Anandamide amidohydrolase inhibitor,O=C(Nc1cnccc1Cl)N1CCN(Cc2ccc3c(c2)OC(F)(F)O3)CC1
SULFASALAZINE,CHEMBL421,Cyclooxygenase inhibitor,O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O
ASPIRIN,CHEMBL25,Cyclooxygenase inhibitor,CC(=O)Oc1ccccc1C(=O)O
IBUPROFEN,CHEMBL521,Cyclooxygenase inhibitor,CC(C)Cc1ccc(C(C)C(=O)O)cc1
DIFLUNISAL,CHEMBL898,Cyclooxygenase inhibitor,O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O
NEPAFENAC,CHEMBL1021,Cyclooxygenase inhibitor,NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N
BISMUTH SUBSALICYLATE,CHEMBL1120,Cyclooxygenase inhibitor,
TOLMETIN SODIUM,CHEMBL1200613,Cyclooxygenase inhibitor,Cc1ccc(C(=O)c2ccc(CC(=O)[O-])n2C)cc1.[Na+]
MECLOFENAMATE SODIUM,CHEMBL1562610,Cyclooxygenase inhibitor,Cc1ccc(Cl)c(Nc2ccccc2C(=O)[O-])c1Cl.O.[Na+]
OXYPHENBUTAZONE,CHEMBL3989676,Cyclooxygenase inhibitor,CCCCC1C(=O)N(c2ccccc2)N(c2ccc(O)cc2)C1=O.O
FLURBIPROFEN SODIUM,CHEMBL3989754,Cyclooxygenase inhibitor,CC(C(=O)[O-])c1ccc(-c2ccccc2)c(F)c1.O.O.[Na+]
INDOMETHACIN,CHEMBL6,Cyclooxygenase inhibitor,COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1
FLURBIPROFEN,CHEMBL563,Cyclooxygenase inhibitor,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1
SULINDAC,CHEMBL15770,Cyclooxygenase inhibitor,CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1
OXAPROZIN POTASSIUM,CHEMBL1200463,Cyclooxygenase inhibitor,O=C([O-])CCc1nc(-c2ccccc2)c(-c2ccccc2)o1.[K+]
BALSALAZIDE DISODIUM,CHEMBL1200760,Cyclooxygenase inhibitor,O=C([O-])CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)[O-])c2)cc1.[Na+].[Na+]
DICLOFENAC POTASSIUM,CHEMBL1200804,Cyclooxygenase inhibitor,O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl.[K+]
OLSALAZINE SODIUM,CHEMBL1201013,Cyclooxygenase inhibitor,O=C([O-])c1cc(/N=N/c2ccc(O)c(C(=O)[O-])c2)ccc1O.[Na+].[Na+]
KETOROLAC TROMETHAMINE,CHEMBL1201124,Cyclooxygenase inhibitor,NC(CO)(CO)CO.O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O
BROMFENAC SODIUM,CHEMBL3181947,Cyclooxygenase inhibitor,Nc1c(CC(=O)[O-])cccc1C(=O)c1ccc(Br)cc1.Nc1c(CC(=O)[O-])cccc1C(=O)c1ccc(Br)cc1.O.O.O.[Na+].[Na+]
INDOMETHACIN SODIUM,CHEMBL3989410,Cyclooxygenase inhibitor,COc1ccc2c(c1)c(CC(=O)[O-])c(C)n2C(=O)c1ccc(Cl)cc1.O.O.O.[Na+]
PIROXICAM,CHEMBL527,Cyclooxygenase inhibitor,CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O
PHENYLBUTAZONE,CHEMBL101,Cyclooxygenase inhibitor,CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O
KETOPROFEN,CHEMBL571,Cyclooxygenase inhibitor,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1
DICLOFENAC,CHEMBL139,Cyclooxygenase inhibitor,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl
MEFENAMIC ACID,CHEMBL686,Cyclooxygenase inhibitor,Cc1cccc(Nc2ccccc2C(=O)O)c1C
MESALAMINE,CHEMBL704,Cyclooxygenase inhibitor,Nc1ccc(O)c(C(=O)O)c1
SUPROFEN,CHEMBL956,Cyclooxygenase inhibitor,CC(C(=O)O)c1ccc(C(=O)c2cccs2)cc1
OXAPROZIN,CHEMBL1071,Cyclooxygenase inhibitor,O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1
IBUPROFEN LYSINE,CHEMBL1201141,Cyclooxygenase inhibitor,CC(C)Cc1ccc(C(C)C(=O)O)cc1.NCCCC[C@H](N)C(=O)O
NAPROXCINOD,CHEMBL2103831,Cyclooxygenase inhibitor,COc1ccc2cc([C@H](C)C(=O)OCCCCO[N+](=O)[O-])ccc2c1
CLOMETACIN,CHEMBL13376,Cyclooxygenase inhibitor,COc1ccc2c(C(=O)c3ccc(Cl)cc3)c(C)n(CC(=O)O)c2c1
FENCLOFENAC,CHEMBL15677,Cyclooxygenase inhibitor,O=C(O)Cc1ccccc1Oc1ccc(Cl)cc1Cl
INDOPROFEN,CHEMBL15870,Cyclooxygenase inhibitor,CC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1
ISOXICAM,CHEMBL53292,Cyclooxygenase inhibitor,Cc1cc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)no1
IBUFENAC,CHEMBL341812,Cyclooxygenase inhibitor,CC(C)Cc1ccc(CC(=O)O)cc1
GLAFENINE,CHEMBL146095,Cyclooxygenase inhibitor,O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12
PIRPROFEN,CHEMBL188952,Cyclooxygenase inhibitor,CC(C(=O)O)c1ccc(N2CC=CC2)c(Cl)c1
DEXIBUPROFEN,CHEMBL175,Cyclooxygenase inhibitor,CC(C)Cc1ccc([C@H](C)C(=O)O)cc1
NAPROXEN ETEMESIL,CHEMBL2105683,Cyclooxygenase inhibitor,COc1ccc2cc([C@H](C)C(=O)OCCS(C)(=O)=O)ccc2c1
DIPYRONE,CHEMBL3989803,Cyclooxygenase inhibitor,Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.O.[Na+]
BENZYDAMINE,CHEMBL12610,Cyclooxygenase inhibitor,CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12
LOXOPROFEN,CHEMBL19299,Cyclooxygenase inhibitor,CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1
DEXKETOPROFEN,CHEMBL75435,Cyclooxygenase inhibitor,C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1
ACEMETACIN,CHEMBL189171,Cyclooxygenase inhibitor,COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1
ESFLURBIPROFEN,CHEMBL435298,Cyclooxygenase inhibitor,C[C@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1
BENZYDAMINE HYDROCHLORIDE,CHEMBL1528134,Cyclooxygenase inhibitor,CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12.Cl
APAZONE,CHEMBL1565476,Cyclooxygenase inhibitor,CCCC1C(=O)N2C(N(C)C)=Nc3ccc(C)cc3N2C1=O
LORNOXICAM,CHEMBL1569487,Cyclooxygenase inhibitor,CN1C(C(=O)Nc2ccccn2)=C(O)c2sc(Cl)cc2S1(=O)=O
ALOXIPRIN,CHEMBL2108222,Cyclooxygenase inhibitor,
BETAMETHASONE,CHEMBL632,Glucocorticoid receptor agonist,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
PREDNISONE,CHEMBL635,Glucocorticoid receptor agonist,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO
CAPSAICIN,CHEMBL294199,Vanilloid receptor opener,COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O
HYDROCORTISONE,CHEMBL389621,Glucocorticoid receptor agonist,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO
TRIAMCINOLONE ACETONIDE,CHEMBL1504,Glucocorticoid receptor agonist,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
HYDROCORTISONE CYPIONATE,CHEMBL1549,Glucocorticoid receptor agonist,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COC(=O)CCC1CCCC1
CLOBETASOL PROPIONATE,CHEMBL1159650,Glucocorticoid receptor agonist,CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
HALCINONIDE,CHEMBL1200845,Glucocorticoid receptor agonist,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1
MEDRYSONE,CHEMBL1201173,Glucocorticoid receptor agonist,CC(=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C
DIFLUPREDNATE,CHEMBL1201749,Glucocorticoid receptor agonist,CCCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
PREDNISOLONE,CHEMBL131,Glucocorticoid receptor agonist,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO
FLUNISOLIDE,CHEMBL1512,Glucocorticoid receptor agonist,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
PARAMETHASONE ACETATE,CHEMBL1200342,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
BETAMETHASONE DIPROPIONATE,CHEMBL1200384,Glucocorticoid receptor agonist,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
HYDROCORTISONE SODIUM SUCCINATE,CHEMBL1200495,Glucocorticoid receptor agonist,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)[O-].[Na+]
FLUOROMETHOLONE,CHEMBL1200600,Glucocorticoid receptor agonist,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
HYDROCORTAMATE HYDROCHLORIDE,CHEMBL1200635,Glucocorticoid receptor agonist,CCN(CC)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C.Cl
BETAMETHASONE SODIUM PHOSPHATE,CHEMBL1200762,Glucocorticoid receptor agonist,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]
LOTEPREDNOL ETABONATE,CHEMBL1200865,Glucocorticoid receptor agonist,CCOC(=O)O[C@]1(C(=O)OCCl)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
PREDNISOLONE TEBUTATE,CHEMBL1200909,Glucocorticoid receptor agonist,CC(C)(C)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
PREDNICARBATE,CHEMBL1200386,Glucocorticoid receptor agonist,CCOC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
BECLOMETHASONE DIPROPIONATE,CHEMBL1200500,Glucocorticoid receptor agonist,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C
BETAMETHASONE ACETATE,CHEMBL1200538,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]1(O)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
DIFLORASONE DIACETATE,CHEMBL1200545,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
FLUMETHASONE PIVALATE,CHEMBL1200877,Glucocorticoid receptor agonist,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C
HALOBETASOL PROPIONATE,CHEMBL1200908,Glucocorticoid receptor agonist,CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
HYDROCORTISONE SODIUM PHOSPHATE,CHEMBL1200968,Glucocorticoid receptor agonist,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]
METHYLPREDNISOLONE SODIUM SUCCINATE,CHEMBL1201081,Glucocorticoid receptor agonist,C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)COC(=O)CCC(=O)[O-])[C@@]2(C)C=CC(=O)C=C12.[Na+]
DESONIDE,CHEMBL1201109,Glucocorticoid receptor agonist,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
DEXAMETHASONE SODIUM PHOSPHATE,CHEMBL2021430,Glucocorticoid receptor agonist,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]
METHYLPREDNISOLONE,CHEMBL650,Glucocorticoid receptor agonist,C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)CO)[C@@]2(C)C=CC(=O)C=C12
TRIAMCINOLONE,CHEMBL1451,Glucocorticoid receptor agonist,C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3C[C@@H](O)[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F
FLUOCINONIDE,CHEMBL1501,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C
FLUTICASONE FUROATE,CHEMBL1676,Glucocorticoid receptor agonist,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)SCF
DESOXIMETASONE,CHEMBL1766,Glucocorticoid receptor agonist,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO
BETAMETHASONE BENZOATE,CHEMBL1200376,Glucocorticoid receptor agonist,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccccc1)C(=O)CO
TRIAMCINOLONE DIACETATE,CHEMBL1200449,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]1(O)[C@H](OC(C)=O)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
HYDROCORTISONE VALERATE,CHEMBL1200562,Glucocorticoid receptor agonist,CCCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
AMCINONIDE,CHEMBL1200732,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C
FLUOROMETHOLONE ACETATE,CHEMBL1201064,Glucocorticoid receptor agonist,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
HYDROCORTISONE ACETATE,CHEMBL1091,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
MOMETASONE FUROATE,CHEMBL1161,Glucocorticoid receptor agonist,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl
HYDROCORTISONE BUTYRATE,CHEMBL1683,Glucocorticoid receptor agonist,CCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
FLUPREDNISOLONE,CHEMBL1200774,Glucocorticoid receptor agonist,C[C@]12C=CC(=O)C=C1[C@@H](F)C[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO
TRIAMCINOLONE HEXACETONIDE,CHEMBL1200878,Glucocorticoid receptor agonist,CC(C)(C)CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C
CLOCORTOLONE PIVALATE,CHEMBL1200975,Glucocorticoid receptor agonist,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C
ALCLOMETASONE DIPROPIONATE,CHEMBL1200989,Glucocorticoid receptor agonist,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@H](C)C[C@H]2[C@H]3[C@H]([C@@H](O)C[C@@]21C)[C@@]1(C)C=CC(=O)C=C1C[C@H]3Cl
PREDNISOLONE SODIUM PHOSPHATE,CHEMBL1201014,Glucocorticoid receptor agonist,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]
MEPREDNISONE,CHEMBL1201148,Glucocorticoid receptor agonist,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO
DEXAMETHASONE ACETATE,CHEMBL1530428,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
FLUOCINOLONE ACETONIDE,CHEMBL989,Glucocorticoid receptor agonist,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
PREDNISOLONE ACETATE,CHEMBL1152,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
BUDESONIDE,CHEMBL1370,Glucocorticoid receptor agonist,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
DEXAMETHASONE,CHEMBL384467,Glucocorticoid receptor agonist,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
BETAMETHASONE VALERATE,CHEMBL1497,Glucocorticoid receptor agonist,CCCCC(=O)O[C@]1(C(=O)CO)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
CORTISONE ACETATE,CHEMBL1650,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C
RIMEXOLONE,CHEMBL1200617,Glucocorticoid receptor agonist,CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
HYDROCORTISONE PROBUTATE,CHEMBL1200953,Glucocorticoid receptor agonist,CCCC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
METHYLPREDNISOLONE ACETATE,CHEMBL1364144,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
CICLESONIDE,CHEMBL2040682,Glucocorticoid receptor agonist,CC(C)C(=O)OCC(=O)[C@@]12O[C@H](C3CCCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C
NITROGLYCERIN,CHEMBL730,Soluble guanylate cyclase activator,O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-]
FLUTICASONE PROPIONATE,CHEMBL1473,Glucocorticoid receptor agonist,CCC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
NITRIC OXIDE,CHEMBL1200689,Soluble guanylate cyclase activator,[N]=O
FLURANDRENOLIDE,CHEMBL1201012,Glucocorticoid receptor agonist,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
DEFLAZACORT,CHEMBL1201891,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C
MAPRACORAT,CHEMBL2103876,Glucocorticoid receptor agonist,Cc1ccc2c(NC[C@](O)(CC(C)(C)c3cc(F)cc4c3OCC4)C(F)(F)F)cccc2n1
CORTIVAZOL,CHEMBL2105842,Glucocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3C=C(C)C4=Cc5c(cnn5-c5ccccc5)C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
HYDROCORTISONE ACEPONATE,CHEMBL2106309,Glucocorticoid receptor agonist,CCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
RESOCORTOL BUTYRATE,CHEMBL2107186,Glucocorticoid receptor agonist,CCCC(=O)O[C@]1(C(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
VAMOROLONE,CHEMBL2348780,Glucocorticoid receptor agonist,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@@]1(O)C(=O)CO
ISOSORBIDE DINITRATE,CHEMBL6622,Soluble guanylate cyclase activator,O=[N+]([O-])O[C@H]1CO[C@H]2[C@@H]1OC[C@H]2O[N+](=O)[O-]
SODIUM NITROPRUSSIDE,CHEMBL136478,Soluble guanylate cyclase activator,
ISOSORBIDE MONONITRATE,CHEMBL1311,Soluble guanylate cyclase activator,O=[N+]([O-])O[C@@H]1CO[C@H]2[C@@H]1OC[C@@H]2O
PENTAERYTHRITOL TETRANITRATE,CHEMBL466659,Soluble guanylate cyclase activator,O=[N+]([O-])OCC(CO[N+](=O)[O-])(CO[N+](=O)[O-])CO[N+](=O)[O-]
CINACIGUAT,CHEMBL1236936,Soluble guanylate cyclase activator,O=C(O)CCCCN(CCc1ccccc1OCc1ccc(CCc2ccccc2)cc1)Cc1ccc(C(=O)O)cc1
CLORAZEPATE DIPOTASSIUM,CHEMBL2096631,GABA-A receptor; anion channel positive allosteric modulator,O=C([O-])C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O.[K+].[K+].[OH-]
ATACIGUAT,CHEMBL2107729,Soluble guanylate cyclase activator,O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cc(Cl)ccc1NS(=O)(=O)c1ccc(Cl)s1
VERICIGUAT,CHEMBL4066936,Soluble guanylate cyclase activator,COC(=O)Nc1c(N)nc(-c2nn(Cc3ccccc3F)c3ncc(F)cc23)nc1N
PRALICIGUAT,CHEMBL4297214,Soluble guanylate cyclase activator,OC(CNc1nc(-c2cc(-c3ccon3)n(Cc3ccccc3F)n2)ncc1F)(C(F)(F)F)C(F)(F)F
RUNCACIGUAT,CHEMBL4650322,Soluble guanylate cyclase activator,C[C@H]([C@H](C(=O)Nc1cc([C@@H](CC(=O)O)C2CC2)ccc1Cl)c1ccc(Cl)cc1)C(F)(F)F
DIAZEPAM,CHEMBL12,GABA-A receptor; anion channel positive allosteric modulator,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21
CHLORDIAZEPOXIDE,CHEMBL451,GABA-A receptor; anion channel positive allosteric modulator,CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1
CLONAZEPAM,CHEMBL452,GABA-A receptor; anion channel positive allosteric modulator,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1
BUTALBITAL,CHEMBL454,GABA-A receptor; anion channel positive allosteric modulator,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O
OXAZEPAM,CHEMBL568,GABA-A receptor; anion channel positive allosteric modulator,O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O
TRIAZOLAM,CHEMBL646,GABA-A receptor; anion channel positive allosteric modulator,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2
ALPRAZOLAM,CHEMBL661,GABA-A receptor; anion channel positive allosteric modulator,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2
CLOBAZAM,CHEMBL70418,GABA-A receptor; anion channel positive allosteric modulator,CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21
ESZOPICLONE,CHEMBL1522,GABA-A receptor; anion channel positive allosteric modulator,CN1CCN(C(=O)O[C@H]2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1
CHLORDIAZEPOXIDE HYDROCHLORIDE,CHEMBL1200703,GABA-A receptor; anion channel positive allosteric modulator,CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1.Cl
METHARBITAL,CHEMBL450,GABA-A receptor; anion channel positive allosteric modulator,CCC1(CC)C(=O)NC(=O)N(C)C1=O
LORAZEPAM,CHEMBL580,GABA-A receptor; anion channel positive allosteric modulator,O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O
METHOHEXITAL SODIUM,CHEMBL30219,GABA-A receptor; anion channel positive allosteric modulator,C=CCC1(C(C)C#CCC)C(=O)N=C([O-])N(C)C1=O.[Na+]
ESTAZOLAM,CHEMBL285674,GABA-A receptor; anion channel positive allosteric modulator,Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2
PRAZEPAM,CHEMBL969,GABA-A receptor; anion channel positive allosteric modulator,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1
MIDAZOLAM HYDROCHLORIDE,CHEMBL1200420,GABA-A receptor; anion channel positive allosteric modulator,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2.Cl
DESFLURANE,CHEMBL1200733,GABA-A receptor; anion channel positive allosteric modulator | Glycine receptor (alpha-1/beta) positive modulator | Potassium channel subfamily K member 10 opener | Potassium channel subfamily K member 18 opener | Potassium channel subfamily K member 2 opener | Potassium channel subfamily K member 3 opener | Potassium channel subfamily K member 9 opener,FC(F)OC(F)C(F)(F)F
METHYPRYLON,CHEMBL1200790,GABA-A receptor; anion channel positive allosteric modulator,CCC1(CC)C(=O)NCC(C)C1=O
TALBUTAL,CHEMBL1200802,GABA-A receptor; anion channel positive allosteric modulator,C=CCC1(C(C)CC)C(=O)NC(=O)NC1=O
BUTABARBITAL SODIUM,CHEMBL1200982,GABA-A receptor; anion channel positive allosteric modulator,CCC(C)C1(CC)C(=O)[N-]C(=O)NC1=O.[Na+]
PENTOBARBITAL,CHEMBL448,GABA-A receptor; anion channel positive allosteric modulator,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
PROPOFOL,CHEMBL526,GABA-A receptor; anion channel positive allosteric modulator,CC(C)c1cccc(C(C)C)c1O
THIOPENTAL SODIUM,CHEMBL738,GABA-A receptor; anion channel positive allosteric modulator,CCCC(C)C1(CC)C(=O)[N-]C(=S)NC1=O.[Na+]
PRIMIDONE,CHEMBL856,GABA-A receptor; anion channel positive allosteric modulator,CCC1(c2ccccc2)C(=O)NCNC1=O
TEMAZEPAM,CHEMBL967,GABA-A receptor; anion channel positive allosteric modulator,CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21
PENTOBARBITAL SODIUM,CHEMBL971,GABA-A receptor; anion channel positive allosteric modulator,CCCC(C)C1(CC)C(=O)N=C([O-])NC1=O.[Na+]
QUAZEPAM,CHEMBL1200472,GABA-A receptor; anion channel positive allosteric modulator,Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21
SEVOFLURANE,CHEMBL1200694,GABA-A receptor; anion channel positive allosteric modulator | Glycine receptor (alpha-1/beta) positive modulator | Potassium channel subfamily K member 10 opener | Potassium channel subfamily K member 18 opener | Potassium channel subfamily K member 2 opener | Potassium channel subfamily K member 3 opener | Potassium channel subfamily K member 9 opener,FCOC(C(F)(F)F)C(F)(F)F
SECOBARBITAL SODIUM,CHEMBL1200903,GABA-A receptor; anion channel positive allosteric modulator,C=CCC1(C(C)CCC)C(=O)[N-]C(=O)NC1=O.[Na+]
THIAMYLAL SODIUM,CHEMBL1201065,GABA-A receptor; anion channel positive allosteric modulator,C=CCC1(C(C)CCC)C(=O)[N-]C(=S)NC1=O.[Na+]
FLUNITRAZEPAM,CHEMBL13280,GABA-A receptor; anion channel positive allosteric modulator,CN1C(=O)CN=C(c2ccccc2F)c2cc([N+](=O)[O-])ccc21
METHAQUALONE,CHEMBL282052,GABA-A receptor; anion channel positive allosteric modulator,Cc1ccccc1-n1c(C)nc2ccccc2c1=O
HALOTHANE,CHEMBL931,GABA-A receptor; anion channel positive allosteric modulator | Glycine receptor (alpha-1/beta) positive modulator | Potassium channel subfamily K member 10 opener | Potassium channel subfamily K member 18 opener | Potassium channel subfamily K member 2 opener | Potassium channel subfamily K member 3 opener | Potassium channel subfamily K member 9 opener,FC(F)(F)C(Cl)Br
HALAZEPAM,CHEMBL970,GABA-A receptor; anion channel positive allosteric modulator,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC(F)(F)F
ISOFLURANE,CHEMBL1256,GABA-A receptor; anion channel positive allosteric modulator | Glycine receptor (alpha-1/beta) positive modulator | Potassium channel subfamily K member 10 opener | Potassium channel subfamily K member 18 opener | Potassium channel subfamily K member 2 opener | Potassium channel subfamily K member 3 opener | Potassium channel subfamily K member 9 opener,FC(F)OC(Cl)C(F)(F)F
GANAXOLONE,CHEMBL1568698,GABA-A receptor; anion channel positive allosteric modulator,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C
PAGOCLONE,CHEMBL2104745,GABA-A receptor; anion channel positive allosteric modulator,CC(C)CCC(=O)CC1c2ccccc2C(=O)N1c1ccc2ccc(Cl)nc2n1
METHAQUALONE HYDROCHLORIDE,CHEMBL2106829,GABA-A receptor; anion channel positive allosteric modulator,Cc1ccccc1-n1c(C)nc2ccccc2c1=O.Cl
FLURAZEPAM HYDROCHLORIDE,CHEMBL3989724,GABA-A receptor; anion channel positive allosteric modulator,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21.Cl.Cl
LOREDIPLON,CHEMBL4303403,GABA-A receptor; anion channel positive allosteric modulator,CC(=O)N(C)c1cc(-c2ccnc3c(C(=O)c4cccs4)cnn23)ccc1F
CHLORAMPHENICOL,CHEMBL130,Bacterial 70S ribosome inhibitor,O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl
MIDAZOLAM,CHEMBL655,GABA-A receptor; anion channel positive allosteric modulator,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2
CLOMETHIAZOLE,CHEMBL315795,GABA-A receptor; anion channel positive allosteric modulator,Cc1ncsc1CCCl
ENFLURANE,CHEMBL1257,Glycine receptor (alpha-1/beta) positive modulator | Potassium channel subfamily K member 10 opener | Potassium channel subfamily K member 18 opener | Potassium channel subfamily K member 2 opener | Potassium channel subfamily K member 3 opener | Potassium channel subfamily K member 9 opener,FC(F)OC(F)(F)C(F)Cl
BREXANOLONE,CHEMBL207538,GABA-A receptor; anion channel positive allosteric modulator,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
CLOTIAZEPAM,CHEMBL1697737,GABA-A receptor; anion channel positive allosteric modulator,CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl
TETRAZEPAM,CHEMBL2105527,GABA-A receptor; anion channel positive allosteric modulator,CN1C(=O)CN=C(C2=CCCCC2)c2cc(Cl)ccc21
CENOBAMATE,CHEMBL3989949,GABA-A receptor; anion channel positive allosteric modulator,NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl
ZURANOLONE,CHEMBL4105630,GABA-A receptor; anion channel positive allosteric modulator,C[C@@]1(O)CC[C@H]2[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc(C#N)cn4)CC[C@@H]32)C1
REMIMAZOLAM BESYLATE,CHEMBL4594301,GABA-A receptor; anion channel positive allosteric modulator,COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21.O=S(=O)(O)c1ccccc1
OXYTETRACYCLINE,CHEMBL1517,Bacterial 70S ribosome inhibitor,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12
ERYTHROMYCIN STEARATE,CHEMBL1200510,Bacterial 70S ribosome inhibitor,CCCCCCCCCCCCCCCCCC(=O)O.CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
CHLORAMPHENICOL SODIUM SUCCINATE,CHEMBL1200729,Bacterial 70S ribosome inhibitor,O=C([O-])CCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc([N+](=O)[O-])cc1.[Na+]
DALFOPRISTIN,CHEMBL1200937,Bacterial 70S ribosome inhibitor,CCN(CC)CCS(=O)(=O)[C@@H]1CCN2C(=O)c3coc(n3)CC(=O)C[C@H](O)/C=C(C)/C=C/CNC(=O)/C=C/[C@@H](C)[C@@H](C(C)C)OC(=O)[C@@H]12
DIRITHROMYCIN,CHEMBL1237072,Bacterial 70S ribosome inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)[C@@H]2N[C@@H](COCCOC)O[C@H]([C@H]2C)[C@]1(C)O
METHACYCLINE HYDROCHLORIDE,CHEMBL2146123,Bacterial 70S ribosome inhibitor,C=C1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@H]12.Cl
CLINDAMYCIN PHOSPHATE,CHEMBL3184512,Bacterial 70S ribosome inhibitor,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](OP(=O)(O)O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1
ERYTHROMYCIN GLUCEPTATE,CHEMBL3545060,Bacterial 70S ribosome inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O.O=C(O)[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
OXYTETRACYCLINE CALCIUM,CHEMBL3989568,Bacterial 70S ribosome inhibitor,CN(C)[C@@H]1C([O-])=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12.CN(C)[C@@H]1C([O-])=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12.[Ca+2]
AMIKACIN SULFATE,CHEMBL4208954,Bacterial 70S ribosome inhibitor,NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O.O=S(=O)(O)O.O=S(=O)(O)O
TELITHROMYCIN,CHEMBL1136,Bacterial 70S ribosome inhibitor,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C
TIGECYCLINE,CHEMBL376140,Bacterial 70S ribosome inhibitor,CN(C)c1cc(NC(=O)CNC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O
TETRACYCLINE,CHEMBL1440,Bacterial 70S ribosome inhibitor,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12
KANAMYCIN SULFATE,CHEMBL1446,Bacterial 70S ribosome inhibitor,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](O)[C@@H](O)[C@@H]1O.O=S(=O)(O)O
TETRACYCLINE HYDROCHLORIDE,CHEMBL454950,Bacterial 70S ribosome inhibitor,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12.Cl
DEMECLOCYCLINE HYDROCHLORIDE,CHEMBL1200474,Bacterial 70S ribosome inhibitor,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@H](O)[C@H]3C[C@@H]12.Cl
ERYTHROMYCIN LACTOBIONATE,CHEMBL1200506,Bacterial 70S ribosome inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O.O=C(O)[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO
CLINDAMYCIN HYDROCHLORIDE,CHEMBL1200588,Bacterial 70S ribosome inhibitor,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@H](C)Cl)N(C)C1.Cl
CLINDAMYCIN PALMITATE HYDROCHLORIDE,CHEMBL1200632,Bacterial 70S ribosome inhibitor,CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](O)[C@@H](O)[C@@H]([C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@H](C)Cl)O[C@@H]1SC.Cl
STREPTOMYCIN SULFATE,CHEMBL3184791,Bacterial 70S ribosome inhibitor,CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]3N=C(N)N)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O.CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N=C(N)N)[C@@H](O)[C@@H]3N=C(N)N)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O
MECLOCYCLINE SULFOSALICYLATE,CHEMBL261772,Bacterial 70S ribosome inhibitor,C=C1c2c(Cl)ccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@H]12.O=C(O)c1cc(S(=O)(=O)O)ccc1O
QUINUPRISTIN,CHEMBL1200649,Bacterial 70S ribosome inhibitor,CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2CC(=O)[C@H](CS[C@@H]3CN4CCC3CC4)CN2C(=O)[C@H](Cc2ccc(N(C)C)cc2)N(C)C(=O)[C@@H]2CCCN2C1=O
MINOCYCLINE HYDROCHLORIDE,CHEMBL1200881,Bacterial 70S ribosome inhibitor,CN(C)c1ccc(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O.Cl
TETRACYCLINE PHOSPHATE COMPLEX,CHEMBL1201071,Bacterial 70S ribosome inhibitor,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12.O=P(O)(O)O
OXYTETRACYCLINE HYDROCHLORIDE,CHEMBL1607480,Bacterial 70S ribosome inhibitor,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12.Cl
CHLORTETRACYCLINE HYDROCHLORIDE,CHEMBL2146063,Bacterial 70S ribosome inhibitor,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12.Cl
PAROMOMYCIN SULFATE,CHEMBL2206196,Bacterial 70S ribosome inhibitor,NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O.O=S(=O)(O)O
ERYTHROMYCIN ESTOLATE,CHEMBL2218877,Bacterial 70S ribosome inhibitor,CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C.CCCCCCCCCCCCOS(=O)(=O)O
NETILMICIN SULFATE,CHEMBL3989829,Bacterial 70S ribosome inhibitor,CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O.CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O
GENTAMICIN SULFATE,CHEMBL6067484,Bacterial 70S ribosome inhibitor,
AZITHROMYCIN,CHEMBL529,Bacterial 70S ribosome inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
ERYTHROMYCIN,CHEMBL532,Bacterial 70S ribosome inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
LINEZOLID,CHEMBL126,Bacterial 70S ribosome inhibitor,CC(=O)NC[C@H]1CN(c2ccc(N3CCOCC3)c(F)c2)C(=O)O1
CLARITHROMYCIN,CHEMBL1741,Bacterial 70S ribosome inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
ERYTHROMYCIN ETHYLSUCCINATE,CHEMBL1200688,Bacterial 70S ribosome inhibitor,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C
DOXYCYCLINE,CHEMBL1200699,Bacterial 70S ribosome inhibitor | Matrix metalloproteinase 13 inhibitor | Matrix metalloproteinase 7 inhibitor | Matrix metalloproteinase 8 inhibitor | Matrix metalloproteinase-1 inhibitor,C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.O
TEDIZOLID PHOSPHATE,CHEMBL2105669,Bacterial 70S ribosome inhibitor,Cn1nnc(-c2ccc(-c3ccc(N4C[C@H](COP(=O)(O)O)OC4=O)cc3F)cn2)n1
DIHYDROSTREPTOMYCIN SULFATE,CHEMBL3188576,Bacterial 70S ribosome inhibitor,CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](NC(=N)N)[C@@H](O)[C@@H]3NC(=N)N)O[C@@H](C)[C@]2(O)CO)O[C@@H](CO)[C@H](O)[C@H]1O.CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](NC(=N)N)[C@@H](O)[C@@H]3NC(=N)N)O[C@@H](C)[C@]2(O)CO)O[C@@H](CO)[C@H](O)[C@H]1O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O
SPECTINOMYCIN HYDROCHLORIDE,CHEMBL3989571,Bacterial 70S ribosome inhibitor,CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@@]3(O)C(=O)C[C@@H](C)O[C@H]3O[C@@H]2[C@H]1O.Cl.Cl.O.O.O.O.O
NEOMYCIN SULFATE,CHEMBL3989769,Bacterial 70S ribosome inhibitor,
RADEZOLID,CHEMBL455461,Bacterial 70S ribosome inhibitor,CC(=O)NC[C@H]1CN(c2ccc(-c3ccc(CNCc4cnn[nH]4)cc3)c(F)c2)C(=O)O1
TEDIZOLID,CHEMBL1257051,Bacterial 70S ribosome inhibitor,Cn1nnc(-c2ccc(-c3ccc(N4C[C@H](CO)OC4=O)cc3F)cn2)n1
DELPAZOLID,CHEMBL1673408,Bacterial 70S ribosome inhibitor,CN1CCN(c2ccc(N3C[C@H](CO)OC3=O)cc2F)C=N1
OMADACYCLINE TOSYLATE,CHEMBL2103854,Bacterial 70S ribosome inhibitor,CN(C)c1cc(CNCC(C)(C)C)c(O)c2c1C[C@H]1C[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C1C2=O.Cc1ccc(S(=O)(=O)O)cc1
ERAVACYCLINE DIHYDROCHLORIDE,CHEMBL2219414,Bacterial 70S ribosome inhibitor,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)c(NC(=O)CN5CCCC5)cc(F)c4C[C@H]3C[C@@H]12.Cl.Cl
PLAZOMICIN SULFATE,CHEMBL2364623,Bacterial 70S ribosome inhibitor,CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CNCCO)=CC[C@H]3N)[C@@H](N)C[C@H]2NC(=O)[C@@H](O)CCN)OC[C@]1(C)O.O=S(=O)(O)O
CONTEZOLID,CHEMBL3287379,Bacterial 70S ribosome inhibitor,O=C1C=CN(c2c(F)cc(N3C[C@H](CNc4ccon4)OC3=O)c(F)c2F)CC1
LEFAMULIN ACETATE,CHEMBL3545309,Bacterial 70S ribosome inhibitor,C=C[C@]1(C)C[C@@H](OC(=O)CS[C@@H]2CC[C@@H](N)C[C@H]2O)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O.CC(=O)O
CADAZOLID,CHEMBL3707376,Bacterial 70S ribosome inhibitor,O=C(O)c1cn(C2CC2)c2cc(N3CCC(O)(COc4ccc(N5C[C@H](CO)OC5=O)cc4F)CC3)c(F)cc2c1=O
DOXYCYCLINE HYCLATE,CHEMBL3989740,Bacterial 70S ribosome inhibitor | Matrix metalloproteinase 13 inhibitor | Matrix metalloproteinase 7 inhibitor | Matrix metalloproteinase 8 inhibitor | Matrix metalloproteinase-1 inhibitor,CCO.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.Cl.Cl.O
BEKANAMYCIN,CHEMBL176,Bacterial 70S ribosome inhibitor,NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)[C@@H](O)[C@@H]1O
SISOMICIN,CHEMBL221886,Bacterial 70S ribosome inhibitor,CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O
JOSAMYCIN,CHEMBL224436,Bacterial 70S ribosome inhibitor,CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1OC(C)=O
LINCOMYCIN,CHEMBL1447,Bacterial 70S ribosome inhibitor,CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1
SPIRAMYCIN,CHEMBL453514,Bacterial 70S ribosome inhibitor,CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O
QUINUPRISTIN/DALFOPRISTIN,CHEMBL3137691,Bacterial 70S ribosome inhibitor,CCN(CC)CCS(=O)(=O)[C@@H]1CCN2C(=O)c3coc(n3)CC(=O)C[C@H](O)/C=C(C)/C=C/CNC(=O)/C=C/[C@@H](C)[C@@H](C(C)C)OC(=O)[C@@H]12.CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2CC(=O)[C@H](CS[C@@H]3CN4CCC3CC4)CN2C(=O)[C@H](Cc2ccc(N(C)C)cc2)N(C)C(=O)[C@@H]2CCCN2C1=O
NEOMYCIN,CHEMBL3989751,Bacterial 70S ribosome inhibitor,
CETHROMYCIN,CHEMBL3989904,Bacterial 70S ribosome inhibitor,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OCC=Cc2cnc3ccccc3c2)C[C@@H](C)C(=O)[C@H](C)[C@H]2NC(=O)O[C@@]21C
CONTEZOLID ACEFOSAMIL,CHEMBL3989966,Bacterial 70S ribosome inhibitor,CC(=O)OP(=O)([O-])N(C[C@H]1CN(c2cc(F)c(N3C=CC(=O)CC3)c(F)c2F)C(=O)O1)c1ccon1.[Na+]
NAFITHROMYCIN,CHEMBL4297519,Bacterial 70S ribosome inhibitor,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2[C@H](/C(N)=N/O[C@@H](C)c3nnc(-c4ccccn4)s3)C(=O)O[C@@]21C
REBIMASTAT,CHEMBL76222,Matrix metalloproteinase 13 inhibitor | Matrix metalloproteinase 8 inhibitor | Matrix metalloproteinase-1 inhibitor,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](S)CCN1C(=O)N(C)C(C)(C)C1=O)C(C)(C)C
CTS-1027,CHEMBL440498,Matrix metalloproteinase 13 inhibitor | Matrix metalloproteinase 8 inhibitor,O=C(NO)C1(CS(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1
APRATASTAT,CHEMBL206815,Matrix metalloproteinase 13 inhibitor,CC1(C)SCCN(S(=O)(=O)c2ccc(OCC#CCO)cc2)[C@H]1C(=O)NO
ERAVACYCLINE,CHEMBL1951095,Bacterial 70S ribosome inhibitor,CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)c(NC(=O)CN5CCCC5)cc(F)c4C[C@H]3C[C@@H]12
GAMITHROMYCIN,CHEMBL2107342,Bacterial 70S ribosome inhibitor,CCCN1C[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@H]1C
DOXYCYCLINE CALCIUM,CHEMBL2364574,Matrix metalloproteinase 13 inhibitor | Matrix metalloproteinase 7 inhibitor | Matrix metalloproteinase 8 inhibitor | Matrix metalloproteinase-1 inhibitor,C[C@H]1c2cccc([O-])c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc([O-])c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.[Ca+2]
TILDIPIROSIN,CHEMBL3039509,Bacterial 70S ribosome inhibitor,CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]2O)[C@@H](CCN2CCCCC2)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CN1CCCCC1
TULATHROMYCIN,CHEMBL6067973,Bacterial 70S ribosome inhibitor,
MARIMASTAT,CHEMBL279785,Matrix metalloproteinase 7 inhibitor | Matrix metalloproteinase-1 inhibitor,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
DESOXYCORTICOSTERONE ACETATE,CHEMBL1200542,Mineralocorticoid receptor agonist,CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
DESOXYCORTICOSTERONE PIVALATE,CHEMBL1200592,Mineralocorticoid receptor agonist,CC(C)(C)C(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
FLUDROCORTISONE ACETATE,CHEMBL1201010,Mineralocorticoid receptor agonist,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
INTERFERON ALFA-2B,CHEMBL1201558,Interferon alpha/beta receptor agonist,
ALDESLEUKIN,CHEMBL1201438,Interleukin-2 receptor agonist,
INTERFERON BETA-1A,CHEMBL1201562,Interferon alpha/beta receptor agonist,
PEGINTERFERON ALFA-2A,CHEMBL1201560,Interferon alpha/beta receptor agonist,
INTERFERON ALFA-2A,CHEMBL2108508,Interferon alpha/beta receptor agonist,
INTERFERON ALFA-N3,CHEMBL2109047,Interferon alpha/beta receptor agonist,
ADALIMUMAB,CHEMBL1201580,TNF-alpha inhibitor,
INTERFERON BETA-1B,CHEMBL1201563,Interferon alpha/beta receptor agonist,
ANAKINRA,CHEMBL1201570,Interleukin-1 receptor antagonist,
INTERFERON ALFACON-1,CHEMBL1201557,Interferon alpha/beta receptor agonist,
PEGINTERFERON ALFA-2B,CHEMBL1201561,Interferon alpha/beta receptor agonist,
INFLIXIMAB,CHEMBL1201581,TNF-alpha inhibitor,
CERTOLIZUMAB PEGOL,CHEMBL1201831,TNF-alpha inhibitor,
ALBINTERFERON ALFA-2B,CHEMBL2107842,Interferon alpha/beta receptor agonist,
PEGINTERFERON BETA-1A,CHEMBL2108677,Interferon alpha/beta receptor agonist,
AMG-108,CHEMBL2109458,Interleukin-1 receptor antagonist,
ETANERCEPT,CHEMBL1201572,TNF-alpha inhibitor,
GOLIMUMAB,CHEMBL1201833,TNF-alpha inhibitor,
OZORALIZUMAB,CHEMBL1743054,TNF-alpha inhibitor,
PEGSUNERCEPT,CHEMBL1743057,TNF-alpha inhibitor,
ONERCEPT,CHEMBL2107911,TNF-alpha inhibitor,
LENERCEPT,CHEMBL2108208,TNF-alpha inhibitor,
NERELIMOMAB,CHEMBL2108566,TNF-alpha inhibitor,
PLACULUMAB,CHEMBL2108739,TNF-alpha inhibitor,
AFELIMOMAB,CHEMBL2108887,TNF-alpha inhibitor,
AZ9773,CHEMBL2109587,TNF-alpha inhibitor,
BEVACIZUMAB,CHEMBL1201583,Vascular endothelial growth factor A inhibitor,
RANIBIZUMAB,CHEMBL1201825,Vascular endothelial growth factor A inhibitor,
AFLIBERCEPT,CHEMBL1742982,Vascular endothelial growth factor A inhibitor,
CONBERCEPT,CHEMBL2108313,Vascular endothelial growth factor A inhibitor,
VANUCIZUMAB,CHEMBL3545259,Vascular endothelial growth factor A inhibitor,
BROLUCIZUMAB,CHEMBL3707357,Vascular endothelial growth factor A inhibitor,
MUPARFOSTAT,CHEMBL4297163,Vascular endothelial growth factor A inhibitor,
ABICIPAR PEGOL,CHEMBL4297684,Vascular endothelial growth factor A inhibitor,
FARICIMAB,CHEMBL4297750,Vascular endothelial growth factor A inhibitor,
REMTOLUMAB,CHEMBL4297863,Interleukin 17A inhibitor | TNF-alpha inhibitor,
ABATACEPT,CHEMBL1201823,T-lymphocyte activation antigen CD80 inhibitor | T-lymphocyte activation antigen CD86 inhibitor,
RILONACEPT,CHEMBL1201830,Interleukin-1 beta inhibitor,
CANAKINUMAB,CHEMBL1201834,Interleukin-1 beta inhibitor,
TOCILIZUMAB,CHEMBL1237022,Interleukin-6 receptor alpha subunit inhibitor,
BELATACEPT,CHEMBL1742990,T-lymphocyte activation antigen CD80 inhibitor | T-lymphocyte activation antigen CD86 inhibitor,
PEGAPTANIB OCTASODIUM,CHEMBL2108752,Vascular endothelial growth factor A inhibitor,
GALIXIMAB,CHEMBL2109191,T-lymphocyte activation antigen CD80 inhibitor,
CDP-484,CHEMBL2109459,Interleukin-1 beta inhibitor,
VOBARILIZUMAB,CHEMBL3833343,Interleukin-6 receptor alpha subunit inhibitor,
LUTIKIZUMAB,CHEMBL4594518,Interleukin-1 beta inhibitor,
RAMIPRIL,CHEMBL1168,Angiotensin-converting enzyme inhibitor,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21
TRANDOLAPRIL,CHEMBL1519,Angiotensin-converting enzyme inhibitor,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@H]2CCCC[C@@H]21
CAPTOPRIL,CHEMBL1560,Angiotensin-converting enzyme inhibitor,C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O
BENAZEPRIL HYDROCHLORIDE,CHEMBL1694,Angiotensin-converting enzyme inhibitor,CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O.Cl
PERINDOPRIL ERBUMINE,CHEMBL1200343,Angiotensin-converting enzyme inhibitor,CC(C)(C)N.CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)OCC
MOEXIPRIL HYDROCHLORIDE,CHEMBL1200534,Angiotensin-converting enzyme inhibitor,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(=O)O.Cl
QUINAPRIL HYDROCHLORIDE,CHEMBL1201011,Angiotensin-converting enzyme inhibitor,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O.Cl
FOSINOPRIL SODIUM,CHEMBL3039596,Angiotensin-converting enzyme inhibitor,CCC(=O)O[C@@H](O[P@](=O)(CCCCc1ccccc1)CC(=O)N1C[C@H](C2CCCCC2)C[C@H]1C(=O)[O-])C(C)C.[Na+]
ENALAPRILAT,CHEMBL3989406,Angiotensin-converting enzyme inhibitor,C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O.O.O
LEVILIMAB,CHEMBL4650406,Interleukin-6 receptor alpha subunit inhibitor,
IMIDAPRIL,CHEMBL317094,Angiotensin-converting enzyme inhibitor,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1C(=O)N(C)C[C@H]1C(=O)O
LISINOPRIL,CHEMBL419213,Angiotensin-converting enzyme inhibitor,NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O.O.O
CILAZAPRIL,CHEMBL515606,Angiotensin-converting enzyme inhibitor,CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCCN2CCC[C@@H](C(=O)O)N2C1=O
DELAPRIL,CHEMBL589583,Angiotensin-converting enzyme inhibitor,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N(CC(=O)O)C1Cc2ccccc2C1
ORPHENADRINE CITRATE,CHEMBL1200395,Glutamate [NMDA] receptor antagonist,Cc1ccccc1C(OCCN(C)C)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O
ENALAPRIL MALEATE,CHEMBL1200659,Angiotensin-converting enzyme inhibitor,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O.O=C(O)/C=C\C(=O)O
SPIRAPRIL HYDROCHLORIDE,CHEMBL1200831,Angiotensin-converting enzyme inhibitor,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O)SCCS2.Cl
ACAMPROSATE CALCIUM,CHEMBL2068724,Glutamate [NMDA] receptor antagonist,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
ILEPATRIL,CHEMBL3187812,Angiotensin-converting enzyme inhibitor,CC(=O)S[C@H](C(=O)N[C@H]1Cc2ccccc2[C@H]2CCC[C@@H](C(=O)O)N2C1=O)C(C)C
PERINDOPRIL ARGININE,CHEMBL3544986,Angiotensin-converting enzyme inhibitor,CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)OCC.N=C(N)NCCC[C@H](N)C(=O)O
FELBAMATE,CHEMBL1094,Glutamate [NMDA] receptor antagonist,NC(=O)OCC(COC(N)=O)c1ccccc1
AMANTADINE HYDROCHLORIDE,CHEMBL1569,Glutamate [NMDA] receptor antagonist | Matrix protein 2 inhibitor,Cl.NC12CC3CC(CC(C3)C1)C2
ORPHENADRINE HYDROCHLORIDE,CHEMBL1201023,Glutamate [NMDA] receptor antagonist,Cc1ccccc1C(OCCN(C)C)c1ccccc1.Cl
GW468816,CHEMBL1207366,Glutamate [NMDA] receptor antagonist,O=C(O)C1C/C(=C2/CCN(c3ccccc3)C2=O)c2ccc(Cl)cc2N1
NERAMEXANE MESYLATE,CHEMBL2106798,Glutamate [NMDA] receptor antagonist,CC1(C)CC(C)(C)CC(C)(N)C1.CS(=O)(=O)O
RALFINAMIDE,CHEMBL2107771,Glutamate [NMDA] receptor antagonist,C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(N)=O
DELUCEMINE,CHEMBL2110814,Glutamate [NMDA] receptor antagonist,CNCCC(c1cccc(F)c1)c1cccc(F)c1
AV-101,CHEMBL3545351,Glutamate [NMDA] receptor antagonist,Nc1cc(Cl)ccc1C(=O)CC(N)C(=O)O
AZD8108,CHEMBL3707355,Glutamate [NMDA] receptor antagonist,
INDANTADOL,CHEMBL3707400,Glutamate [NMDA] receptor antagonist,
SAQUINAVIR,CHEMBL114,Human immunodeficiency virus type 1 protease inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1
AMPRENAVIR,CHEMBL116,Human immunodeficiency virus type 1 protease inhibitor,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1
SAQUINAVIR MESYLATE,CHEMBL282042,Human immunodeficiency virus type 1 protease inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1.CS(=O)(=O)O
LOPINAVIR,CHEMBL729,Human immunodeficiency virus type 1 protease inhibitor,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O
RITONAVIR,CHEMBL163,Cytochrome P450 3A inhibitor | Human immunodeficiency virus type 1 protease inhibitor,CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1
NELFINAVIR MESYLATE,CHEMBL1205,Human immunodeficiency virus type 1 protease inhibitor,CS(=O)(=O)O.Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C
PERZINFOTEL,CHEMBL452461,Glutamate [NMDA] receptor antagonist,O=c1c2c(c1=O)N(CCP(=O)(O)O)CCCN2
FOSAMPRENAVIR CALCIUM,CHEMBL1200734,Human immunodeficiency virus type 1 protease inhibitor,CC(C)CN(C[C@@H](OP(=O)([O-])[O-])[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1.[Ca+2]
COBICISTAT,CHEMBL2095208,Cytochrome P450 3A inhibitor,CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1
TCN-032,CHEMBL2109619,Matrix protein 2 inhibitor,
MERIMEPODIB,CHEMBL304087,Inosine-5'-monophosphate dehydrogenase 1 inhibitor,COc1cc(NC(=O)Nc2cccc(CNC(=O)O[C@H]3CCOC3)c2)ccc1-c1cnco1
TELINAVIR,CHEMBL322241,Human immunodeficiency virus type 1 protease inhibitor,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1)C(=O)NC(C)(C)C
DARUNAVIR,CHEMBL1323,Human immunodeficiency virus type 1 protease inhibitor,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1
BRECANAVIR,CHEMBL206031,Human immunodeficiency virus type 1 protease inhibitor,Cc1nc(COc2ccc(C[C@H](NC(=O)O[C@H]3CO[C@H]4OCC[C@H]43)[C@H](O)CN(CC(C)C)S(=O)(=O)c3ccc4c(c3)OCO4)cc2)cs1
TIPRANAVIR,CHEMBL222559,Human immunodeficiency virus type 1 protease inhibitor,CCC[C@@]1(CCc2ccccc2)CC(O)=C([C@H](CC)c2cccc(NS(=O)(=O)c3ccc(C(F)(F)F)cn3)c2)C(=O)O1
RIBAVIRIN,CHEMBL1643,Inosine-5'-monophosphate dehydrogenase 1 inhibitor | RNA inhibitor | RNA-directed RNA polymerase inhibitor,NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1
INDINAVIR SULFATE,CHEMBL1735,Human immunodeficiency virus type 1 protease inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O.O=S(=O)(O)O
CAPECITABINE,CHEMBL1773,RNA inhibitor,CCCCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1F
ATAZANAVIR SULFATE,CHEMBL1200678,Human immunodeficiency virus type 1 protease inhibitor,COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C.O=S(=O)(O)O
DARUNAVIR ETHANOLATE,CHEMBL1201127,Human immunodeficiency virus type 1 protease inhibitor,CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1.CCO
CARMUSTINE,CHEMBL513,RNA inhibitor,O=NN(CCCl)C(=O)NCCCl
TEGAFUR,CHEMBL20883,RNA inhibitor,O=c1[nH]c(=O)n(C2CCCO2)cc1F
CYTARABINE,CHEMBL803,RNA inhibitor,Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1
FLUOROURACIL,CHEMBL185,RNA inhibitor,O=c1[nH]cc(F)c(=O)[nH]1
FAVIPIRAVIR,CHEMBL221722,RNA-directed RNA polymerase inhibitor,NC(=O)c1nc(F)cnc1O
AZACITIDINE,CHEMBL1489,RNA inhibitor,Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1
SOFOSBUVIR,CHEMBL1259059,RNA-directed RNA polymerase inhibitor,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1
HYDROXYSTILBAMIDINE ISETHIONATE,CHEMBL2023895,RNA inhibitor,N=C(N)c1ccc(/C=C/c2ccc(C(=N)N)cc2O)cc1.O=S(=O)(O)CCO.O=S(=O)(O)CCO
ELACYTARABINE,CHEMBL2105665,RNA inhibitor,CCCCCCCC/C=C/CCCCCCCC(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@@H](O)[C@@H]1O
DASABUVIR SODIUM MONOHYDRATE,CHEMBL3544985,RNA-directed RNA polymerase inhibitor,COc1c(-c2ccc3cc(NS(C)(=O)=O)ccc3c2)cc(-n2ccc(=O)[n-]c2=O)cc1C(C)(C)C.O.[Na+]
FILIBUVIR,CHEMBL490672,RNA-directed RNA polymerase inhibitor,CCc1cc(CC[C@]2(C3CCCC3)CC(O)=C(Cc3nc4nc(C)cc(C)n4n3)C(=O)O2)cc(CC)n1
BALAPIRAVIR,CHEMBL550936,RNA-directed RNA polymerase inhibitor,CC(C)C(=O)OC[C@@]1(N=[N+]=[N-])O[C@@H](n2ccc(N)nc2=O)[C@H](OC(=O)C(C)C)[C@@H]1OC(=O)C(C)C
MERICITABINE,CHEMBL562967,RNA-directed RNA polymerase inhibitor,CC(C)C(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@](C)(F)[C@@H]1OC(=O)C(C)C
SETROBUVIR,CHEMBL1076263,RNA-directed RNA polymerase inhibitor,CS(=O)(=O)Nc1ccc2c(c1)S(=O)(=O)N=C(C1=C(O)[C@@H]3[C@H]4CC[C@H](C4)[C@@H]3N(Cc3ccc(F)cc3)C1=O)N2
BMS-986094,CHEMBL1209734,RNA-directed RNA polymerase inhibitor,COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(N[C@@H](C)C(=O)OCC(C)(C)C)Oc2cccc3ccccc23)[C@@H](O)[C@@]1(C)O
PSI-352938,CHEMBL2160007,RNA-directed RNA polymerase inhibitor,CCOc1nc(N)nc2c1ncn2[C@@H]1O[C@@H]2COP(=O)(OC(C)C)O[C@H]2[C@@]1(C)F
DELEOBUVIR,CHEMBL2403318,RNA-directed RNA polymerase inhibitor,Cn1c(C2(NC(=O)c3ccc4c(C5CCCC5)c(-c5ncc(Br)cn5)n(C)c4c3)CCC2)nc2ccc(/C=C/C(=O)O)cc21
RADALBUVIR,CHEMBL3121539,RNA-directed RNA polymerase inhibitor,CC1=CC[C@H](C(=O)N(c2cc(C#CC(C)(C)C)sc2C(=O)O)[C@H]2CC[C@](O)(CO[C@H]3CCOC3)CC2)CC1
ABT-072,CHEMBL4076467,RNA-directed RNA polymerase inhibitor,COc1c(/C=C/c2ccc(NS(C)(=O)=O)cc2)cc(-n2ccc(=O)[nH]c2=O)cc1C(C)(C)C
ADAFOSBUVIR,CHEMBL4129286,RNA-directed RNA polymerase inhibitor,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@@]1(F)O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(O)[C@@H]1O)Oc1ccccc1
CHLOROQUINE PHOSPHATE,CHEMBL58510,Ferriprotoporphyrin IX inhibitor,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=P(O)(O)O.O=P(O)(O)O
VALOPICITABINE,CHEMBL393820,RNA-directed RNA polymerase inhibitor,CC(C)[C@H](N)C(=O)O[C@@H]1[C@@H](CO)O[C@@H](n2ccc(N)nc2=O)[C@]1(C)O
MEFLOQUINE HYDROCHLORIDE,CHEMBL535650,Ferriprotoporphyrin IX inhibitor,Cl.OC(c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)C1CCCCN1
ARTEMETHER,CHEMBL566534,Ferriprotoporphyrin IX inhibitor,CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3
NESBUVIR,CHEMBL1092581,RNA-directed RNA polymerase inhibitor,CNC(=O)c1c(-c2ccc(F)cc2)oc2cc(N(CCO)S(C)(=O)=O)c(C3CC3)cc12
HALOFANTRINE HYDROCHLORIDE,CHEMBL1200901,Ferriprotoporphyrin IX inhibitor,CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12.Cl
AMODIAQUINE HYDROCHLORIDE,CHEMBL1357648,Ferriprotoporphyrin IX inhibitor,CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O.Cl.Cl.O.O
TEGOBUVIR,CHEMBL1957287,RNA-directed RNA polymerase inhibitor,Fc1ccccc1-c1nc2ccn(Cc3ccc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)nn3)cc-2n1
TMC-647055,CHEMBL2043025,RNA-directed RNA polymerase inhibitor,COc1ccc2c(c1)C=C1Cn3c-2c(C2CCCCC2)c2ccc(cc23)C(=O)NS(=O)(=O)N(C)CCOCCN(C)C1=O
UPRIFOSBUVIR,CHEMBL3833371,RNA-directed RNA polymerase inhibitor,CC(C)OC(=O)[C@@H](C)N[P@@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(Cl)[C@@H]1O)Oc1ccccc1
TADALAFIL,CHEMBL779,Phosphodiesterase 5A inhibitor,CN1CC(=O)N2[C@H](c3ccc4c(c3)OCO4)c3[nH]c4ccccc4c3C[C@@H]2C1=O
LUMEFANTRINE,CHEMBL38827,Ferriprotoporphyrin IX inhibitor,CCCCN(CCCC)CC(O)c1cc(Cl)cc2c1-c1ccc(Cl)cc1/C2=C/c1ccc(Cl)cc1
PIPERAQUINE,CHEMBL303933,Ferriprotoporphyrin IX inhibitor,Clc1ccc2c(N3CCN(CCCN4CCN(c5ccnc6cc(Cl)ccc56)CC4)CC3)ccnc2c1
VARDENAFIL HYDROCHLORIDE,CHEMBL1339,Phosphodiesterase 5A inhibitor,CCCc1nc(C)c2c(O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)nn12.Cl
HYDROXYCHLOROQUINE SULFATE,CHEMBL1690,Ferriprotoporphyrin IX inhibitor | Toll-like receptor 7 antagonist | Toll-like receptor 9 antagonist,CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=S(=O)(O)O
SILDENAFIL CITRATE,CHEMBL1737,Phosphodiesterase 5A inhibitor,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12.O=C(O)CC(O)(CC(=O)O)C(=O)O
AVANAFIL,CHEMBL1963681,Phosphodiesterase 5A inhibitor,COc1ccc(CNc2nc(N3CCC[C@H]3CO)ncc2C(=O)NCc2ncccn2)cc1Cl
QUININE SULFATE,CHEMBL2359966,Ferriprotoporphyrin IX inhibitor,C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12.C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12.O.O.O=S(=O)(O)O
BAZLITORAN,CHEMBL4297995,Toll-like receptor 7 antagonist | Toll-like receptor 9 antagonist,
ENPATORAN,CHEMBL4802159,Toll-like receptor 7 antagonist,N#Cc1ccc(N2C[C@H](N)C[C@H](C(F)(F)F)C2)c2cccnc12
IBUDILAST,CHEMBL19449,Phosphodiesterase 4 inhibitor | Phosphodiesterase 5A inhibitor,CC(C)C(=O)c1c(C(C)C)nn2ccccc12
PF-03049423,CHEMBL591501,Phosphodiesterase 5A inhibitor,CCCOCCn1c(=O)c(N2CCN(CCO)CC2)nc2cnc(-c3ccc(OC)nc3)cc21
ITOLIZUMAB,CHEMBL1743033,T-cell differentiation antigen CD6 inhibitor,
IXEKIZUMAB,CHEMBL1743034,Interleukin 17A inhibitor,
SECUKINUMAB,CHEMBL1743068,Interleukin 17A inhibitor,
GISADENAFIL,CHEMBL1928262,Phosphodiesterase 5A inhibitor,CCOc1ncc(S(=O)(=O)N2CCN(CC)CC2)cc1-c1nc2c(CC)n(CCOC)nc2c(=O)[nH]1
UDENAFIL,CHEMBL2103849,Phosphodiesterase 5A inhibitor,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc2c(CCC)nn(C)c2c(=O)[nH]1
AFASEVIKUMAB,CHEMBL2109469,Interleukin 17A inhibitor,
PERAKIZUMAB,CHEMBL2109470,Interleukin 17A inhibitor,
PF-00489791,CHEMBL4210847,Phosphodiesterase 5A inhibitor,CCOCCn1nc(C(=O)NS(C)(=O)=O)c2nc(N(C)CC)nc(Nc3cc(C)ccn3)c21
OLOKIZUMAB,CHEMBL1743050,Interleukin-6 inhibitor,
SIRUKUMAB,CHEMBL1743071,Interleukin-6 inhibitor,
CLAZAKIZUMAB,CHEMBL2108589,Interleukin-6 inhibitor,
ELSILIMOMAB,CHEMBL2108591,Interleukin-6 inhibitor,
TIBULIZUMAB,CHEMBL3990000,Interleukin 17A inhibitor,
IZOKIBEP,CHEMBL4297686,Interleukin 17A inhibitor,
BIMEKIZUMAB,CHEMBL4297700,Interleukin 17A inhibitor,
M-1095,CHEMBL4298023,Interleukin 17A inhibitor,
VUNAKIZUMAB,CHEMBL4298102,Interleukin 17A inhibitor,
PACIBEKITUG,CHEMBL6068160,Interleukin-6 inhibitor,
REPARIXIN,CHEMBL191413,Interleukin-8 receptor A modulator | Interleukin-8 receptor B modulator,CC(C)Cc1ccc([C@@H](C)C(=O)NS(C)(=O)=O)cc1
LADARIXIN,CHEMBL189475,Interleukin-8 receptor A modulator | Interleukin-8 receptor B modulator,C[C@@H](C(=O)NS(C)(=O)=O)c1ccc(OS(=O)(=O)C(F)(F)F)cc1
PHENOXYBENZAMINE HYDROCHLORIDE,CHEMBL1200787,Adrenergic receptor alpha antagonist,CC(COc1ccccc1)N(CCCl)Cc1ccccc1.Cl
PHENTOLAMINE MESYLATE,CHEMBL1200873,Adrenergic receptor alpha antagonist,CS(=O)(=O)O.Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
ALSEROXYLON,CHEMBL1201454,Adrenergic receptor alpha antagonist,
SILTUXIMAB,CHEMBL1743070,Interleukin-6 antagonist,
MRA 003 US,CHEMBL2109615,Interleukin-6 inhibitor,
ERGOLOID MESYLATES,CHEMBL2311030,Adrenergic receptor alpha antagonist,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CCC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O
RAUWOLFIA SERPENTINA,CHEMBL3559672,Adrenergic receptor alpha antagonist,
ZILTIVEKIMAB,CHEMBL4297732,Interleukin-6 inhibitor,
MOXISYLYTE,CHEMBL159226,Adrenergic receptor alpha antagonist,CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C
RIVAROXABAN,CHEMBL198362,Coagulation factor X inhibitor,O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1
APIXABAN,CHEMBL231779,Coagulation factor X inhibitor,COc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(N4CCCCC4=O)cc2)CC3)cc1
BETRIXABAN,CHEMBL512351,Coagulation factor X inhibitor,COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1
TOLAZOLINE HYDROCHLORIDE,CHEMBL1689,Adrenergic receptor alpha antagonist,Cl.c1ccc(CC2=NCCN2)cc1
LETAXABAN,CHEMBL1095032,Coagulation factor X inhibitor,O=C([C@H](O)CS(=O)(=O)c1ccc2cc(Cl)ccc2c1)N1CCC(N2CCCNC2=O)CC1
ANTITHROMBIN ALFA,CHEMBL1201554,Coagulation factor X inhibitor,
AVIPTADIL,CHEMBL1981592,Adrenergic receptor alpha antagonist,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O
EDOXABAN TOSYLATE,CHEMBL2105682,Coagulation factor X inhibitor,CN1CCc2nc(C(=O)N[C@@H]3C[C@@H](C(=O)N(C)C)CC[C@@H]3NC(=O)C(=O)Nc3ccc(Cl)cn3)sc2C1.Cc1ccc(S(=O)(=O)O)cc1
IDRAPARINUX SODIUM,CHEMBL5314374,Coagulation factor X inhibitor,CO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]2O[C@@H](C(=O)[O-])[C@@H](O[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]4O[C@H](C(=O)[O-])[C@@H](O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](OC)[C@H](OC)[C@H]5OC)[C@H](OC)[C@H]4OC)[C@H](OS(=O)(=O)[O-])[C@H]3OS(=O)(=O)[O-])[C@H](OC)[C@H]2OC)[C@H](OS(=O)(=O)[O-])[C@H]1OS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
OTAMIXABAN,CHEMBL46618,Coagulation factor X inhibitor,COC(=O)[C@H](Cc1cccc(C(=N)N)c1)[C@@H](C)NC(=O)c1ccc(-c2cc[n+]([O-])cc2)cc1
RUXOLITINIB PHOSPHATE,CHEMBL1795071,Tyrosine-protein kinase JAK1 inhibitor | Tyrosine-protein kinase JAK2 inhibitor,N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1.O=P(O)(O)O
DAREXABAN,CHEMBL1922235,Coagulation factor X inhibitor,COc1ccc(C(=O)Nc2cccc(O)c2NC(=O)c2ccc(N3CCCN(C)CC3)cc2)cc1
TRICETAMIDE,CHEMBL2106468,Tyrosine-protein kinase JAK1 inhibitor,CCN(CC)C(=O)CNC(=O)c1cc(OC)c(OC)c(OC)c1
FILGOTINIB,CHEMBL3301607,Tyrosine-protein kinase JAK1 inhibitor | Tyrosine-protein kinase JAK2 inhibitor,O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1
GLPG-0555,CHEMBL3545249,Tyrosine-protein kinase JAK1 inhibitor,
ABROCITINIB,CHEMBL3655081,Tyrosine-protein kinase JAK1 inhibitor,CCCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1
BEMIPARIN,CHEMBL3707365,Coagulation factor X inhibitor,
CERDULATINIB,CHEMBL4116008,Tyrosine-protein kinase JAK1 inhibitor,CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1
IDRABIOTAPARINUX SODIUM,CHEMBL4297768,Coagulation factor X inhibitor,
MOMELOTINIB,CHEMBL1078178,Tyrosine-protein kinase JAK1 inhibitor | Tyrosine-protein kinase JAK2 inhibitor,N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1
BARICITINIB,CHEMBL2105759,Tyrosine-protein kinase JAK1 inhibitor | Tyrosine-protein kinase JAK2 inhibitor,CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1
SOLCITINIB,CHEMBL3301606,Tyrosine-protein kinase JAK1 inhibitor,CC1(C)CN(C(=O)c2ccc(-c3cccc4nc(NC(=O)C5CC5)nn34)cc2)C1
INCB-047986,CHEMBL3545225,Tyrosine-protein kinase JAK1 inhibitor,
ITACITINIB,CHEMBL3622820,Tyrosine-protein kinase JAK1 inhibitor,N#CCC1(n2cc(-c3ncnc4[nH]ccc34)cn2)CN(C2CCN(C(=O)c3ccnc(C(F)(F)F)c3F)CC2)C1
BREPOCITINIB,CHEMBL4297477,Tyrosine-protein kinase JAK1 inhibitor,Cn1cc(Nc2nccc(N3C[C@H]4CC[C@@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1
FILGOTINIB MALEATE,CHEMBL4298167,Tyrosine-protein kinase JAK1 inhibitor | Tyrosine-protein kinase JAK2 inhibitor,O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1.O=C(O)/C=C\C(=O)O
GOLIDOCITINIB,CHEMBL4577523,Tyrosine-protein kinase JAK1 inhibitor,COc1nn(C)cc1Nc1nccc(-c2c[nH]c3c(NC(=O)[C@@H](C)N4CCN(C)CC4)cccc23)n1
DEURUXOLITINIB PHOSPHATE,CHEMBL4594382,Tyrosine-protein kinase JAK1 inhibitor | Tyrosine-protein kinase JAK2 inhibitor,O=P(O)(O)O.[2H]C1([2H])C([C@@H](CC#N)n2cc(-c3ncnc4[nH]ccc34)cn2)C([2H])([2H])C([2H])([2H])C1([2H])[2H]
UPADACITINIB HEMIHYDRATE,CHEMBL5315119,Tyrosine-protein kinase JAK1 inhibitor | Tyrosine-protein kinase JAK2 inhibitor,CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12.CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12.O
AT-9283,CHEMBL495727,Tyrosine-protein kinase JAK2 inhibitor,O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1
AZD-1480,CHEMBL1231124,Tyrosine-protein kinase JAK2 inhibitor,Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1
ZOTIRACICLIB,CHEMBL1944698,Tyrosine-protein kinase JAK2 inhibitor,CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1
CT-1578,CHEMBL2035185,Tyrosine-protein kinase JAK2 inhibitor,C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2ccc(o2)COC/1
GANDOTINIB,CHEMBL2107823,Tyrosine-protein kinase JAK2 inhibitor,Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)n[nH]1
BMS-911543,CHEMBL3545215,Tyrosine-protein kinase JAK2 inhibitor,CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21
AC-430,CHEMBL3545241,Tyrosine-protein kinase JAK2 inhibitor,Cc1cc(Nc2nc(C(O)c3ccc(F)cc3)nc3ccccc23)n[nH]1
XL-019,CHEMBL3545328,Tyrosine-protein kinase JAK2 inhibitor,O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1
LS-104,CHEMBL5095023,Tyrosine-protein kinase JAK2 inhibitor,N#C/C(=C\C=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1
MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE,CHEMBL6068336,Tyrosine-protein kinase JAK1 inhibitor | Tyrosine-protein kinase JAK2 inhibitor,Cl.Cl.N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1.O
LESTAURTINIB,CHEMBL603469,Tyrosine-protein kinase JAK2 inhibitor,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O
ENOXAPARIN SODIUM,CHEMBL1201476,Antithrombin-III activator,
TINZAPARIN SODIUM,CHEMBL1201414,Antithrombin-III activator,
FEDRATINIB,CHEMBL1287853,Tyrosine-protein kinase JAK2 inhibitor,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1
PACRITINIB,CHEMBL2035187,Tyrosine-protein kinase JAK2 inhibitor,C1=N/C2=N/c3ccc(OCCN4CCCC4)c(c3)COC/C=C/COCc3cccc(c3)C(=C1)N2
PEGINTERFERON LAMBDA-1A,CHEMBL2108723,Interferon lambda receptor agonist,
SARILUMAB,CHEMBL2108730,Interleukin-6 receptor alpha subunit antagonist,
FEDRATINIB HYDROCHLORIDE,CHEMBL4297216,Tyrosine-protein kinase JAK2 inhibitor,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1.Cl.Cl.O
NS-018,CHEMBL4303389,Tyrosine-protein kinase JAK2 inhibitor,C[C@H](Nc1cc(-c2cnn(C)c2)cc(Nc2cnccn2)n1)c1ccc(F)cc1
PACRITINIB CITRATE,CHEMBL5095049,Tyrosine-protein kinase JAK2 inhibitor,C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1.O=C(O)CC(O)(CC(=O)O)C(=O)O
FONDAPARINUX SODIUM,CHEMBL1200644,Antithrombin-III activator,CO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]2O[C@@H](C(=O)[O-])[C@@H](O[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]4O[C@H](C(=O)[O-])[C@@H](O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](O)[C@H](O)[C@H]5NS(=O)(=O)[O-])[C@H](O)[C@H]4O)[C@H](OS(=O)(=O)[O-])[C@H]3NS(=O)(=O)[O-])[C@H](O)[C@H]2OS(=O)(=O)[O-])[C@H](O)[C@H]1NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
ARDEPARIN SODIUM,CHEMBL1201448,Antithrombin-III activator,
HEPARIN CALCIUM,CHEMBL1201513,Antithrombin-III activator,
HEPARIN SODIUM,CHEMBL1201657,Antithrombin-III activator,
DALTEPARIN SODIUM,CHEMBL1201460,Antithrombin-III activator,
DANAPAROID SODIUM,CHEMBL1201534,Antithrombin-III activator,
PARNAPARIN SODIUM,CHEMBL2108080,Antithrombin-III activator,
BEMIPARIN SODIUM,CHEMBL2108806,Antithrombin-III activator,
NADROPARIN CALCIUM,CHEMBL2109204,Antithrombin-III activator,
HEPARIN,CHEMBL4650299,Antithrombin-III activator,
MARAVIROC,CHEMBL256907,C-C chemokine receptor type 5 antagonist,Cc1nnc(C(C)C)n1[C@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1
APLAVIROC HYDROCHLORIDE,CHEMBL1668019,C-C chemokine receptor type 5 antagonist,CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2.Cl
INCB-9471,CHEMBL1688243,C-C chemokine receptor type 5 antagonist,CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C
AZD5672,CHEMBL1951914,C-C chemokine receptor type 5 antagonist,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)C2CCN(S(C)(=O)=O)CC2)CC1
VICRIVIROC MALEATE,CHEMBL2107384,C-C chemokine receptor type 5 antagonist,COC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C.O=C(O)/C=C\C(=O)O
LERONLIMAB,CHEMBL2109343,C-C chemokine receptor type 5 antagonist,
CENICRIVIROC,CHEMBL2110727,C-C chemokine receptor type 2 antagonist | C-C chemokine receptor type 5 antagonist,CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1
ILACIRNON,CHEMBL2178573,C-C chemokine receptor type 2 antagonist,Cc1cnc(C(=O)c2ncnc3[nH]ccc23)c(NS(=O)(=O)c2ccc(Cl)c(C(F)(F)F)c2)c1
BMS-813160,CHEMBL4594419,C-C chemokine receptor type 2 antagonist | C-C chemokine receptor type 5 antagonist,CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O
PF-04634817,CHEMBL5095029,C-C chemokine receptor type 2 antagonist | C-C chemokine receptor type 5 antagonist,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2C[C@@H]3C[C@H]2CN3c2cc(C(F)(F)F)ncn2)(C(C)C)C1
PF-4136309,CHEMBL2029422,C-C chemokine receptor type 2 antagonist,O=C(NCC(=O)N1CC[C@H](N[C@H]2CC[C@@](O)(c3ccc(-c4ncccn4)cn3)CC2)C1)c1cccc(C(F)(F)F)c1
RG-7652,CHEMBL2109539,Subtilisin/kexin type 9 inhibitor,
ALIROCUMAB,CHEMBL2109540,Subtilisin/kexin type 9 inhibitor,
JNJ-41443532,CHEMBL2204263,C-C chemokine receptor type 2 antagonist,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@@](O)(c3cncs3)CC2)C1
EVOLOCUMAB,CHEMBL2364655,Subtilisin/kexin type 9 inhibitor,
BOCOCIZUMAB,CHEMBL3137349,Subtilisin/kexin type 9 inhibitor,
RALPANCIZUMAB,CHEMBL3137352,Subtilisin/kexin type 9 inhibitor,
MK-0812,CHEMBL3305901,C-C chemokine receptor type 2 antagonist,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)(C(C)C)C1
AZD2423,CHEMBL3545221,C-C chemokine receptor type 2 antagonist,
BMS-741672,CHEMBL4457723,C-C chemokine receptor type 2 antagonist,CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](Nc3ncnc4ccc(C(F)(F)F)cc34)C2=O)[C@H](NS(C)(=O)=O)C1
ALOGLIPTIN BENZOATE,CHEMBL227529,Dipeptidyl peptidase IV inhibitor,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O.O=C(O)c1ccccc1
LINAGLIPTIN,CHEMBL237500,Dipeptidyl peptidase IV inhibitor,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C
GOSOGLIPTIN,CHEMBL515387,Dipeptidyl peptidase IV inhibitor,O=C([C@@H]1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CCC(F)(F)C1
CARMEGLIPTIN,CHEMBL591118,Dipeptidyl peptidase IV inhibitor,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](N3C[C@@H](CF)CC3=O)CN1CC2
SITAGLIPTIN PHOSPHATE,CHEMBL1201174,Dipeptidyl peptidase IV inhibitor,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F.O.O=P(O)(O)O
SAXAGLIPTIN HYDROCHLORIDE,CHEMBL1201743,Dipeptidyl peptidase IV inhibitor,Cl.N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2
FROVOCIMAB,CHEMBL4298016,Subtilisin/kexin type 9 inhibitor,
TAFOLECIMAB,CHEMBL4594554,Subtilisin/kexin type 9 inhibitor,
ONGERICIMAB,CHEMBL4594566,Subtilisin/kexin type 9 inhibitor,
LERODALCIBEP,CHEMBL4650405,Subtilisin/kexin type 9 inhibitor,
VILDAGLIPTIN,CHEMBL142703,Dipeptidyl peptidase IV inhibitor,N#C[C@@H]1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2
EVOGLIPTIN,CHEMBL1779710,Dipeptidyl peptidase IV inhibitor,CC(C)(C)OC[C@@H]1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F
ANAGLIPTIN,CHEMBL1929396,Dipeptidyl peptidase IV inhibitor,Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)cn2n1
TRELAGLIPTIN SUCCINATE,CHEMBL2105754,Dipeptidyl peptidase IV inhibitor,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O.O=C(O)CCC(=O)O
OMARIGLIPTIN,CHEMBL2105762,Dipeptidyl peptidase IV inhibitor,CS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2
TENELIGLIPTIN,CHEMBL2147777,Dipeptidyl peptidase IV inhibitor,Cc1cc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)n(-c2ccccc2)n1
GEMIGLIPTIN,CHEMBL3707235,Dipeptidyl peptidase IV inhibitor,N[C@@H](CC(=O)N1CCc2c(nc(C(F)(F)F)nc2C(F)(F)F)C1)CN1CC(F)(F)CCC1=O
BEGELOMAB,CHEMBL3833357,Dipeptidyl peptidase IV inhibitor,
DUTOGLIPTIN,CHEMBL4296719,Dipeptidyl peptidase IV inhibitor,O=C(CN[C@@H]1CCNC1)N1CCC[C@H]1B(O)O
BISEGLIPTIN,CHEMBL4297624,Dipeptidyl peptidase IV inhibitor,CCOC(=O)C12CCC(NCC(=O)N3C[C@@H](F)C[C@H]3C#N)(CC1)CC2
NICOTINE,CHEMBL3,Neuronal acetylcholine receptor; alpha4/beta2 agonist,CN1CCC[C@H]1c1cccnc1
SOFINICLINE,CHEMBL238465,Neuronal acetylcholine receptor; alpha4/beta2 agonist,Clc1cc(N2C[C@@H]3CN[C@@H]3C2)cnc1Cl
DBPR-108,CHEMBL1082462,Dipeptidyl peptidase IV inhibitor,CC(C)(CC(=O)N1CCCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N
NICOTINE POLACRILEX,CHEMBL1201536,Neuronal acetylcholine receptor; alpha4/beta2 agonist,
TEBANICLINE TOSYLATE,CHEMBL2104964,Neuronal acetylcholine receptor; alpha4/beta2 agonist,Cc1ccc(S(=O)(=O)O)cc1.Clc1ccc(OC[C@H]2CCN2)cn1
AZD1446,CHEMBL2179529,Neuronal acetylcholine receptor; alpha4/beta2 agonist,O=C(c1ccc(Cl)o1)N1CC2CNCC2C1
SIMPINICLINE,CHEMBL4594254,Neuronal acetylcholine receptor; alpha4/beta2 agonist,C(=C/[C@H]1CCNC1)\c1cncnc1
SITAGLIPTIN FUMARATE,CHEMBL5315049,Dipeptidyl peptidase IV inhibitor,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F.O=C(O)/C=C\C(=O)O
VARENICLINE TARTRATE,CHEMBL6067972,Neuronal acetylcholine receptor; alpha4/beta2 agonist,O=C(O)[C@H](O)[C@@H](O)C(=O)O.c1cnc2cc3c(cc2n1)[C@@H]1CNC[C@H]3C1
SITAGLIPTIN HYDROCHLORIDE MONOHYDRATE,CHEMBL6068334,Dipeptidyl peptidase IV inhibitor,Cl.N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F.O
DNK333,CHEMBL105060,Neurokinin 1 receptor antagonist,CN(C(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](/C=C/C(=O)N[C@@H]1CCCCNC1=O)Cc1ccc(Cl)c(Cl)c1
ALTINICLINE,CHEMBL111659,Neuronal acetylcholine receptor; alpha4/beta2 agonist,C#Cc1cncc([C@@H]2CCCN2C)c1
NETUPITANT,CHEMBL206253,Neurokinin 1 receptor antagonist,Cc1ccccc1-c1cc(N2CCN(C)CC2)ncc1N(C)C(=O)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1
APREPITANT,CHEMBL1471,Neurokinin 1 receptor antagonist,C[C@@H](O[C@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1
SERLOPITANT,CHEMBL447955,Neurokinin 1 receptor antagonist,C[C@@H](O[C@H]1CC[C@@H]2CN(C3=CC(=O)CC3)C[C@H]2[C@@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1
FOSAPREPITANT DIMEGLUMINE,CHEMBL1201782,Neurokinin 1 receptor antagonist,CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.C[C@@H](O[C@H]1OCCN(Cc2nn(P(=O)(O)O)c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1
FIGOPITANT,CHEMBL2104927,Neurokinin 1 receptor antagonist,CN(CCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)[C@H](c1ccccc1)N1CCN(CC2CC2)CC1
VESTIPITANT MESYLATE,CHEMBL2104992,Neurokinin 1 receptor antagonist,CS(=O)(=O)O.Cc1cc(F)ccc1[C@H]1CNCCN1C(=O)N(C)[C@H](C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1
ORVEPITANT,CHEMBL2105667,Neurokinin 1 receptor antagonist,Cc1cc(F)ccc1[C@H]1C[C@@H](N2CCN3C(=O)CC[C@H]3C2)CCN1C(=O)N(C)[C@H](C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1
ROLAPITANT HYDROCHLORIDE,CHEMBL3707330,Neurokinin 1 receptor antagonist,C[C@@H](OC[C@@]1(c2ccccc2)CC[C@]2(CCC(=O)N2)CN1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1.Cl.O
VOFOPITANT,CHEMBL522302,Neurokinin 1 receptor antagonist,COc1ccc(-n2nnnc2C(F)(F)F)cc1CN[C@H]1CCCN[C@H]1c1ccccc1
EZLOPITANT,CHEMBL515966,Neurokinin 1 receptor antagonist,COc1ccc(C(C)C)cc1CN[C@H]1C2CCN(CC2)[C@H]1C(c1ccccc1)c1ccccc1
APROTININ,CHEMBL1201619,Plasma kallikrein inhibitor | Plasminogen inhibitor,
ECALLANTIDE,CHEMBL1201837,Plasma kallikrein inhibitor,
CASOPITANT,CHEMBL1672054,Neurokinin 1 receptor antagonist,CC(=O)N1CCN([C@H]2CCN(C(=O)N(C)[C@H](C)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)[C@@H](c3ccc(F)cc3C)C2)CC1
BURAPITANT,CHEMBL3544947,Neurokinin 1 receptor antagonist,CC(C)(C(N)=O)C1CCN(CCC2(c3ccc(Cl)c(Cl)c3)CN(C(=O)Cc3cc(C(F)(F)F)cc(C(F)(F)F)c3)CCO2)CC1
TRADIPITANT,CHEMBL3544984,Neurokinin 1 receptor antagonist,O=C(c1ccccc1Cl)c1cccnc1-c1nnn(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c1-c1ccncc1
LANADELUMAB,CHEMBL3545189,Plasma kallikrein inhibitor,
FOSNETUPITANT CHLORIDE HYDROCHLORIDE,CHEMBL3989919,Neurokinin 1 receptor antagonist,Cc1ccccc1-c1cc(N2CC[N+](C)(COP(=O)(O)O)CC2)ncc1N(C)C(=O)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1.Cl.[Cl-]
ELINZANETANT,CHEMBL4802157,Neurokinin 1 receptor antagonist,Cc1cc(F)ccc1-c1cc(N2C[C@H]3COCCN3C[C@H]2CO)ncc1N(C)C(=O)C(C)(C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1
NAMILUMAB,CHEMBL1743044,Granulocyte-macrophage colony-stimulating factor inhibitor,
IBRUTINIB,CHEMBL1873475,Tyrosine-protein kinase BTK inhibitor,C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1
GIMSILUMAB,CHEMBL2109430,Granulocyte-macrophage colony-stimulating factor inhibitor,
OTILIMAB,CHEMBL2109433,Granulocyte-macrophage colony-stimulating factor inhibitor,
SPEBRUTINIB BESYLATE,CHEMBL3301600,Tyrosine-protein kinase BTK inhibitor,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1.O=S(=O)(O)c1ccccc1
LENZILUMAB,CHEMBL3707325,Granulocyte-macrophage colony-stimulating factor inhibitor,
POSELTINIB,CHEMBL4163691,Tyrosine-protein kinase BTK inhibitor,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccoc23)c1
AVORALSTAT,CHEMBL4297502,Plasma kallikrein inhibitor,C=Cc1cc(C(=O)Nc2ccc(C(=N)N)cc2)c(-c2ccc(C(=O)NCC3CC3)nc2C(=O)O)cc1OC
HUMAN C1-ESTERASE INHIBITOR,CHEMBL4297549,Plasma kallikrein inhibitor,
BEROTRALSTAT HYDROCHLORIDE,CHEMBL6067995,Plasma kallikrein inhibitor,Cl.Cl.N#Cc1cccc([C@@H](NCC2CC2)c2ccc(F)c(NC(=O)c3cc(C(F)(F)F)nn3-c3cccc(CN)c3)c2)c1
MSC-2364447,CHEMBL3545193,Tyrosine-protein kinase BTK inhibitor,
RILZABRUTINIB,CHEMBL3702854,Tyrosine-protein kinase BTK inhibitor,CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCN(C2COC2)CC1
ACALABRUTINIB,CHEMBL3707348,Tyrosine-protein kinase BTK inhibitor,CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12
BMS-986142,CHEMBL3900554,Tyrosine-protein kinase BTK inhibitor,Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O
ZANUBRUTINIB,CHEMBL3936761,Tyrosine-protein kinase BTK inhibitor,C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1
FENEBRUTINIB,CHEMBL4065122,Tyrosine-protein kinase BTK inhibitor,C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1
TIRABRUTINIB,CHEMBL4071161,Tyrosine-protein kinase BTK inhibitor,CC#CC(=O)N1CC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1
EVOBRUTINIB,CHEMBL4072833,Tyrosine-protein kinase BTK inhibitor,C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1
BRANEBRUTINIB,CHEMBL4297674,Tyrosine-protein kinase BTK inhibitor,CC#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1
ELSUBRUTINIB,CHEMBL4594348,Tyrosine-protein kinase BTK inhibitor,C=CC(=O)N1CCC[C@@H](c2ccc(C(N)=O)c3[nH]ccc23)C1
TICAGRELOR,CHEMBL398435,Purinergic receptor P2Y12 negative allosteric modulator,CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1
BRENSOCATIB,CHEMBL3900409,Dipeptidyl peptidase I inhibitor,Cn1c(=O)oc2ccc(-c3ccc(C[C@@H](C#N)NC(=O)[C@@H]4CNCCCO4)cc3)cc21
VECABRUTINIB,CHEMBL4297640,Tyrosine-protein kinase BTK inhibitor,NC(=O)[C@H]1CCN(c2ncnc(N)c2F)C[C@@H]1N1CCC[C@@H](Nc2cc(Cl)cc(C(F)(F)F)c2)C1=O
ABIVERTINIB,CHEMBL4297865,Tyrosine-protein kinase BTK inhibitor,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)c1
ABIVERTINIB MALEATE,CHEMBL4297866,Tyrosine-protein kinase BTK inhibitor,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)c1.O.O.O=C(O)/C=C\C(=O)O
ACALABRUTINIB MALEATE,CHEMBL4594293,Tyrosine-protein kinase BTK inhibitor,CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12.O=C(O)/C=C\C(=O)O
ORELABRUTINIB,CHEMBL4650321,Tyrosine-protein kinase BTK inhibitor,C=CC(=O)N1CCC(c2ccc(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)n2)CC1
TOLEBRUTINIB,CHEMBL4650323,Tyrosine-protein kinase BTK inhibitor,C=CC(=O)N1CCC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)nccc32)C1
EDRALBRUTINIB,CHEMBL4650338,Tyrosine-protein kinase BTK inhibitor,CC#CC(=O)N1CC[C@@H](n2cc(-c3ccc(Oc4c(F)cccc4F)cc3)c3c(N)n[nH]c(=O)c32)C1
PIRTOBRUTINIB,CHEMBL4650485,Tyrosine-protein kinase BTK inhibitor,COc1ccc(F)cc1C(=O)NCc1ccc(-c2nn([C@@H](C)C(F)(F)F)c(N)c2C(N)=O)cc1
RETASPIMYCIN HYDROCHLORIDE,CHEMBL377559,Heat shock protein HSP90 inhibitor,C=CCNc1c(O)cc2c(O)c1C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)N2.Cl
AGATOLIMOD SODIUM,CHEMBL2103793,Toll-like receptor 9 agonist,Cc1cn([C@H]2C[C@H](OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4ccc(N)nc4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4ccc(N)nc4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4ccc(N)nc4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4ccc(N)nc4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3O)[C@@H](CO)O2)c(=O)[nH]c1=O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
GANETESPIB,CHEMBL2103879,Heat shock protein HSP90 inhibitor,CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3c(ccn3C)c2)c(O)cc1O
COBITOLIMOD,CHEMBL4297564,Toll-like receptor 9 agonist,
1018 ISS,CHEMBL4297680,Toll-like receptor 9 agonist,
CD24FC,CHEMBL4297717,Heat shock 70 kDa protein 1A/1B inhibitor | Heat shock protein HSP90 inhibitor | High mobility group protein B1 inhibitor | Sialic acid-binding Ig-like lectin 10 modulator,
LEFITOLIMOD,CHEMBL4297776,Toll-like receptor 9 agonist,
TILSOTOLIMOD,CHEMBL4297838,Toll-like receptor 9 agonist,
EMD-1201081,CHEMBL4297993,Toll-like receptor 9 agonist,
TILSOTOLIMOD SODIUM,CHEMBL4297994,Toll-like receptor 9 agonist,
TANESPIMYCIN,CHEMBL109480,Heat shock protein HSP90 inhibitor,C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O
ALVESPIMYCIN,CHEMBL383824,Heat shock protein HSP90 inhibitor,CO[C@H]1/C=C\C=C(/C)C(=O)NC2=CC(=O)C(NCCN(C)C)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O)C2=O
LUMINESPIB,CHEMBL252164,Heat shock protein HSP90 inhibitor,CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1
BIIB021,CHEMBL467399,Heat shock protein HSP90 inhibitor,COc1c(C)cnc(Cn2cnc3c(Cl)nc(N)nc32)c1C
SNX 5422,CHEMBL1195136,Heat shock protein HSP90 inhibitor,CC1(C)CC(=O)c2c(C(F)(F)F)nn(-c3ccc(C(N)=O)c(N[C@H]4CC[C@H](OC(=O)CN)CC4)c3)c2C1
ECULIZUMAB,CHEMBL1201828,Complement C5 inhibitor,
ONALESPIB,CHEMBL1214827,Heat shock protein HSP90 inhibitor,CC(C)c1cc(C(=O)N2Cc3ccc(CN4CCN(C)CC4)cc3C2)c(O)cc1O
PEXELIZUMAB,CHEMBL2107979,Complement C5 inhibitor,
ROPEGINTERFERON ALFA-2B,CHEMBL4297819,Interferon alpha/beta receptor positive modulator,
ASUNERCEPT,CHEMBL4297886,Tumor necrosis factor ligand superfamily member 6 binding agent,
EMPAGLIFLOZIN,CHEMBL2107830,Sodium/glucose cotransporter 2 inhibitor,OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(O[C@H]4CCOC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O
VILOBELIMAB,CHEMBL2109636,Complement C5 inhibitor,
RAVULIZUMAB,CHEMBL3989986,Complement C5 inhibitor,
OLENDALIZUMAB,CHEMBL3990025,Complement C5 inhibitor,
AVACINCAPTAD PEGOL SODIUM,CHEMBL4297889,Complement C5 inhibitor,
NOMACOPAN,CHEMBL4297928,Complement C5 inhibitor,
POZELIMAB,CHEMBL4298086,Complement C5 inhibitor,
ZILUCOPLAN,CHEMBL4298207,Complement C5 inhibitor,
CANAGLIFLOZIN,CHEMBL4594217,Sodium/glucose cotransporter 2 inhibitor,Cc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc(-c2ccc(F)cc2)s1.O
CROVALIMAB,CHEMBL4594316,Complement C5 inhibitor,
DAPAGLIFLOZIN,CHEMBL429910,Sodium/glucose cotransporter 2 inhibitor,CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1
SERGLIFLOZIN ETABONATE,CHEMBL450044,Sodium/glucose cotransporter 2 inhibitor,CCOC(=O)OC[C@H]1O[C@@H](Oc2ccccc2Cc2ccc(OC)cc2)[C@H](O)[C@@H](O)[C@@H]1O
ERTUGLIFLOZIN,CHEMBL1770248,Sodium/glucose cotransporter 2 inhibitor,CCOc1ccc(Cc2cc([C@]34OC[C@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O)ccc2Cl)cc1
BEXAGLIFLOZIN,CHEMBL1808388,Sodium/glucose cotransporter 2 inhibitor,OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(OCCOC4CC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O
REMOGLIFLOZIN ETABONATE,CHEMBL2028665,Sodium/glucose cotransporter 2 inhibitor,CCOC(=O)OC[C@H]1O[C@@H](Oc2nn(C(C)C)c(C)c2Cc2ccc(OC(C)C)cc2)[C@H](O)[C@@H](O)[C@@H]1O
DAPAGLIFLOZIN PROPANEDIOL,CHEMBL2103802,Sodium/glucose cotransporter 2 inhibitor,CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1.C[C@H](O)CO.O
TOFOGLIFLOZIN,CHEMBL2105711,Sodium/glucose cotransporter 2 inhibitor,CCc1ccc(Cc2ccc3c(c2)[C@]2(OC3)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1.O
SOTAGLIFLOZIN,CHEMBL3039507,Sodium/glucose cotransporter 2 inhibitor,CCOc1ccc(Cc2cc([C@@H]3O[C@H](SC)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1
LICOGLIFLOZIN,CHEMBL4297625,Sodium/glucose cotransporter 2 inhibitor,CCc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc2c(c1)OCCO2
IPRAGLIFLOZIN L-PROLINE,CHEMBL4297658,Sodium/glucose cotransporter 2 inhibitor,O=C(O)[C@@H]1CCCN1.OC[C@H]1O[C@@H](c2ccc(F)c(Cc3cc4ccccc4s3)c2)[C@H](O)[C@@H](O)[C@@H]1O
AMLEXANOX,CHEMBL1096,Phosphodiesterase 4 inhibitor,CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1
ROFLUMILAST,CHEMBL193240,Phosphodiesterase 4 inhibitor,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1
PLITIDEPSIN,CHEMBL451930,Elongation factor 1-alpha 2 inhibitor,CC[C@H](C)[C@H]1NC(=O)[C@@H](NC(=O)[C@@H](CC(C)C)N(C)C(=O)[C@@H]2CCCN2C(=O)C(C)=O)[C@@H](C)OC(=O)[C@H](Cc2ccc(OC)cc2)N(C)C(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)C(=O)[C@H](C(C)C)OC(=O)C[C@@H]1O
DYPHYLLINE,CHEMBL1752,Phosphodiesterase 4 inhibitor,Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O
THEOPHYLLINE SODIUM GLYCINATE,CHEMBL1200578,Phosphodiesterase 4 inhibitor,Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCC(=O)[O-].[Na+]
THEOPHYLLINE,CHEMBL1355736,Phosphodiesterase 4 inhibitor,Cn1c(=O)c2nc[nH]c2n(C)c1=O.O
IPRAGLIFLOZIN,CHEMBL2018096,Sodium/glucose cotransporter 2 inhibitor,OC[C@H]1O[C@@H](c2ccc(F)c(Cc3cc4ccccc4s3)c2)[C@H](O)[C@@H](O)[C@@H]1O
HENAGLIFLOZIN,CHEMBL4297431,Sodium/glucose cotransporter 2 inhibitor,CCOc1ccc(Cc2cc([C@@]34OC[C@@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O)ccc2Cl)cc1F
YM-543,CHEMBL4297452,Sodium/glucose cotransporter 2 inhibitor,C[N+](C)(C)CCO.[O-]c1ccc(Cc2cc3cccccc-3c2)cc1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
ERTUGLIFLOZIN PIDOLATE,CHEMBL5315054,Sodium/glucose cotransporter 2 inhibitor,CCOc1ccc(Cc2cc([C@]34OC[C@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O)ccc2Cl)cc1.O=C1CC[C@@H](C(=O)O)N1
APREMILAST,CHEMBL514800,Phosphodiesterase 4 inhibitor,CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC
CRISABOROLE,CHEMBL484785,Phosphodiesterase 4 inhibitor,N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1
DROTAVERINE,CHEMBL551978,Phosphodiesterase 4 inhibitor,CCOc1ccc(/C=C2\NCCc3cc(OCC)c(OCC)cc32)cc1OCC
GSK-256066,CHEMBL570015,Phosphodiesterase 4 inhibitor,COc1cccc(Nc2c(C(N)=O)cnc3c(C)cc(S(=O)(=O)c4cccc(C(=O)N(C)C)c4)cc23)c1
OXTRIPHYLLINE,CHEMBL1200434,Phosphodiesterase 4 inhibitor,C[N+](C)(C)CCO.Cn1c(=O)c2[n-]cnc2n(C)c1=O
FLAVOXATE HYDROCHLORIDE,CHEMBL1200875,Phosphodiesterase 4 inhibitor,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O.Cl
AMINOPHYLLINE,CHEMBL1370561,Phosphodiesterase 4 inhibitor,Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN
TRANIMILAST,CHEMBL3113974,Phosphodiesterase 4 inhibitor,CS(=O)(=O)Nc1ccc(C(=O)O[C@@H](Cc2c(Cl)c[n+]([O-])cc2Cl)c2ccc(OC(F)F)c(OCC3CC3)c2)cc1OCC1CC1
DIFAMILAST,CHEMBL3989968,Phosphodiesterase 4 inhibitor,CCOc1ccccc1C(=O)NCc1coc(-c2ccc(OC(F)F)c(OC(C)C)c2)n1
DOVRAMILAST,CHEMBL4297460,Phosphodiesterase 4 inhibitor,CCOc1cc([C@@H](CS(C)(=O)=O)N2Cc3cccc(NC(=O)C4CC4)c3C2=O)ccc1OC
ROLIPRAM,CHEMBL63,Phosphodiesterase 4 inhibitor,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1
TETOMILAST,CHEMBL332750,Phosphodiesterase 4 inhibitor,CCOc1ccc(-c2nc(-c3cccc(C(=O)O)n3)cs2)cc1OCC
TOFIMILAST,CHEMBL217899,Phosphodiesterase 4 inhibitor,CCc1nn(C2CCCC2)c2c1CCn1c(-c3cccs3)nnc1-2
CILOMILAST,CHEMBL511115,Phosphodiesterase 4 inhibitor,COc1ccc([C@]2(C#N)CC[C@@H](C(=O)O)CC2)cc1OC1CCCC1
MK-0873,CHEMBL485629,Phosphodiesterase 4 inhibitor,O=C(NC1CC1)c1cn(-c2cccc(C#Cc3ccc[n+]([O-])c3)c2)c2ncccc2c1=O
LOTAMILAST,CHEMBL3989967,Phosphodiesterase 4 inhibitor,CNc1nc(-c2cccc(NC(=O)c3ccc(C(=O)OC)cc3)c2)c2cc(OC)c(OC)cc2n1
HT-0712,CHEMBL4297287,Phosphodiesterase 4 inhibitor,COc1ccc([C@H]2CNC(=O)[C@H](Cc3cccc(C)c3)C2)cc1OC1CCCC1
OGLEMILAST,CHEMBL4297520,Phosphodiesterase 4 inhibitor,CS(=O)(=O)Nc1ccc2oc3c(OC(F)F)ccc(C(=O)Nc4c(Cl)cncc4Cl)c3c2c1
REVAMILAST,CHEMBL4297527,Phosphodiesterase 4 inhibitor,O=C(Nc1c(Cl)c[n+]([O-])cc1Cl)c1ccc(OC(F)F)c2oc3ccncc3c12
ENSIFENTRINE,CHEMBL4594287,Phosphodiesterase 4 inhibitor,COc1cc2c(cc1OC)-c1c/c(=N\c3c(C)cc(C)cc3C)n(CCNC(N)=O)c(=O)n1CC2
TRETINOIN,CHEMBL38,Retinoic acid receptor agonist,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1
ISOTRETINOIN,CHEMBL547,Retinoic acid receptor agonist,CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1
ADAPALENE,CHEMBL1265,Retinoic acid receptor agonist,COc1ccc(-c2ccc3cc(C(=O)O)ccc3c2)cc1C12CC3CC(CC(C3)C1)C2
TAZAROTENE,CHEMBL1657,Retinoic acid receptor agonist,CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1
LOPERAMIDE HYDROCHLORIDE,CHEMBL1707,Mu opioid receptor agonist,CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1.Cl
ALFENTANIL HYDROCHLORIDE,CHEMBL1200531,Mu opioid receptor agonist,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCn2nnn(CC)c2=O)CC1.Cl
DIFENOXIN HYDROCHLORIDE,CHEMBL1200599,Mu opioid receptor agonist,Cl.N#CC(CCN1CCC(C(=O)O)(c2ccccc2)CC1)(c1ccccc1)c1ccccc1
HYDROMORPHONE HYDROCHLORIDE,CHEMBL1237055,Mu opioid receptor agonist,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@H]3[C@H]1C5.Cl
TRAMADOL HYDROCHLORIDE,CHEMBL1237065,Mu opioid receptor agonist,COc1cccc(C2(O)CCCCC2CN(C)C)c1.Cl
OXYCODONE TEREPHTHALATE,CHEMBL3989826,Mu opioid receptor agonist,COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314.COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314.O=C(O)c1ccc(C(=O)O)cc1
FENTANYL CITRATE,CHEMBL688,Mu opioid receptor agonist,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O
MEPERIDINE HYDROCHLORIDE,CHEMBL1701,Mu opioid receptor agonist,CCOC(=O)C1(c2ccccc2)CCN(C)CC1.Cl
DIPHENOXYLATE HYDROCHLORIDE,CHEMBL1200665,Mu opioid receptor agonist,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1.Cl
METHADONE HYDROCHLORIDE,CHEMBL1200825,Mu opioid receptor agonist,CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1.Cl
OXYCODONE HYDROCHLORIDE,CHEMBL1200890,Mu opioid receptor agonist,COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314.Cl
FENTANYL HYDROCHLORIDE,CHEMBL1201159,Mu opioid receptor agonist,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl
PROPOXYPHENE HYDROCHLORIDE,CHEMBL1237104,Mu opioid receptor agonist,CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C.Cl
MORPHINE SULFATE,CHEMBL2103744,Mu opioid receptor agonist,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.O.O.O.O.O.O=S(=O)(O)O
PROPOXYPHENE NAPSYLATE,CHEMBL3989716,Mu opioid receptor agonist,CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C.O.O=S(=O)(O)c1ccc2ccccc2c1
LEVORPHANOL TARTRATE,CHEMBL3989768,Mu opioid receptor agonist,CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13.O.O.O=C(O)C(O)C(O)C(=O)O
FENTANYL,CHEMBL596,Mu opioid receptor agonist,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1
BUPRENORPHINE,CHEMBL511142,Mu opioid receptor agonist,CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5
ANILERIDINE PHOSPHATE,CHEMBL1200543,Mu opioid receptor agonist,CCOC(=O)C1(c2ccccc2)CCN(CCc2ccc(N)cc2)CC1.O=P(O)(O)O
LEVOMETHADYL ACETATE HYDROCHLORIDE,CHEMBL1200817,Mu opioid receptor agonist,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(c1ccccc1)c1ccccc1.Cl
ANILERIDINE HYDROCHLORIDE,CHEMBL1201047,Mu opioid receptor agonist,CCOC(=O)C1(c2ccccc2)CCN(CCc2ccc(N)cc2)CC1.Cl
REMIFENTANIL HYDROCHLORIDE,CHEMBL1201120,Mu opioid receptor agonist,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1.Cl
SUFENTANIL CITRATE,CHEMBL1201163,Mu opioid receptor agonist,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O
TAPENTADOL HYDROCHLORIDE,CHEMBL1201777,Mu opioid receptor agonist,CC[C@@H](c1cccc(O)c1)[C@@H](C)CN(C)C.Cl
DIHYDROCODEINE BITARTRATE,CHEMBL2062266,Mu opioid receptor agonist,COc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@H]4[C@@H](C2)N(C)CC[C@@]341.O=C(O)C(O)C(O)C(=O)O
BUPRENORPHINE HYDROCHLORIDE,CHEMBL2368861,Mu opioid receptor agonist,CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5.Cl
OXYCODONE,CHEMBL656,Mu opioid receptor agonist,COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314
LOXAPINE,CHEMBL831,D2-like dopamine receptor antagonist | Serotonin 2a (5-HT2a) receptor antagonist,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1
LEVOMETHADYL ACETATE,CHEMBL1514,Mu opioid receptor agonist,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(c1ccccc1)c1ccccc1
DIACETYLMORPHINE,CHEMBL459324,Mu opioid receptor agonist,CC(=O)Oc1ccc2c3c1O[C@H]1[C@@H](OC(C)=O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341
FAXELADOL,CHEMBL2103829,Mu opioid receptor agonist,CN(C)C[C@@H]1CCCC[C@H]1c1cccc(O)c1
ELUXADOLINE,CHEMBL2159122,Mu opioid receptor agonist,COc1ccc(CN(C(=O)[C@@H](N)Cc2c(C)cc(C(N)=O)cc2C)[C@@H](C)c2ncc(-c3ccccc3)[nH]2)cc1C(=O)O
OLICERIDINE,CHEMBL2443262,Mu opioid receptor agonist,COc1ccsc1CNCC[C@@]1(c2ccccn2)CCOC2(CCCC2)C1
FRAKEFAMIDE,CHEMBL3989481,Mu opioid receptor agonist,C[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
AXOMADOL,CHEMBL3989680,Mu opioid receptor agonist,COc1cccc(C2(O)CC(O)CCC2CN(C)C)c1
OXYCODEGOL,CHEMBL4297632,Mu opioid receptor agonist,COCCOCCOCCOCCOCCOCCO[C@H]1CCC2(O)[C@H]3Cc4ccc(OC)c5c4[C@@]2(CCN3C)[C@H]1O5
THIORIDAZINE,CHEMBL479,D2-like dopamine receptor antagonist | Serotonin 2a (5-HT2a) receptor antagonist,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2
CHLORPROMAZINE,CHEMBL71,D2-like dopamine receptor antagonist | Serotonin 2a (5-HT2a) receptor antagonist,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21
DROPERIDOL,CHEMBL1108,D2-like dopamine receptor antagonist | Serotonin 2a (5-HT2a) receptor antagonist,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
CHLORPROMAZINE HYDROCHLORIDE,CHEMBL1713,D2-like dopamine receptor antagonist | Serotonin 2a (5-HT2a) receptor antagonist,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21.Cl
LEVOMEPROMAZINE,CHEMBL1764,D2-like dopamine receptor antagonist,COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2
PROMAZINE HYDROCHLORIDE,CHEMBL1200469,D2-like dopamine receptor antagonist | Serotonin 2a (5-HT2a) receptor antagonist,CN(C)CCCN1c2ccccc2Sc2ccccc21.Cl
THIORIDAZINE HYDROCHLORIDE,CHEMBL1200916,D2-like dopamine receptor antagonist | Serotonin 2a (5-HT2a) receptor antagonist,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2.Cl
LOXAPINE HYDROCHLORIDE,CHEMBL1201060,D2-like dopamine receptor antagonist | Serotonin 2a (5-HT2a) receptor antagonist,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1.Cl
LOXAPINE SUCCINATE,CHEMBL1201155,D2-like dopamine receptor antagonist | Serotonin 2a (5-HT2a) receptor antagonist,CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1.O=C(O)CCC(=O)O
OLANZAPINE PAMOATE,CHEMBL3989694,D2-like dopamine receptor antagonist | Serotonin 2a (5-HT2a) receptor antagonist,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1.O.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O
CLOZAPINE,CHEMBL42,Serotonin 2a (5-HT2a) receptor antagonist,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
OLANZAPINE,CHEMBL715,D2-like dopamine receptor antagonist | Serotonin 2a (5-HT2a) receptor antagonist,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHLORPROTHIXENE,CHEMBL908,Serotonin 2a (5-HT2a) receptor antagonist,CN(C)CC/C=C1/c2ccccc2Sc2ccc(Cl)cc21
ARIPIPRAZOLE,CHEMBL1112,Serotonin 2a (5-HT2a) receptor antagonist,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CYCLOBENZAPRINE HYDROCHLORIDE,CHEMBL1200636,Serotonin 2a (5-HT2a) receptor antagonist,CN(C)CCC=C1c2ccccc2C=Cc2ccccc21.Cl
TRAZODONE HYDROCHLORIDE,CHEMBL1200798,Serotonin 2a (5-HT2a) receptor antagonist,Cl.O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12
TRIFLUOPERAZINE HYDROCHLORIDE,CHEMBL1257040,D2-like dopamine receptor antagonist | Serotonin 2a (5-HT2a) receptor antagonist,CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1.Cl.Cl
LURASIDONE HYDROCHLORIDE,CHEMBL1615372,Serotonin 2a (5-HT2a) receptor antagonist,Cl.O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1
CARPHENAZINE MALEATE,CHEMBL2358147,Serotonin 2a (5-HT2a) receptor antagonist,CCC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2.O=C(O)/C=C\C(=O)O.O=C(O)/C=C\C(=O)O
ASENAPINE MALEATE,CHEMBL3544974,Serotonin 2a (5-HT2a) receptor antagonist,CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1.O=C(O)/C=C\C(=O)O
HALOPERIDOL,CHEMBL54,Serotonin 2a (5-HT2a) receptor antagonist,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
RISPERIDONE,CHEMBL85,Serotonin 2a (5-HT2a) receptor antagonist,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
MIRTAZAPINE,CHEMBL654,Serotonin 2a (5-HT2a) receptor antagonist,CN1CCN2c3ncccc3Cc3ccccc3C2C1
PIMOZIDE,CHEMBL1423,Serotonin 2a (5-HT2a) receptor antagonist,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
PALIPERIDONE,CHEMBL1621,Serotonin 2a (5-HT2a) receptor antagonist,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O
MOLINDONE HYDROCHLORIDE,CHEMBL1200419,Serotonin 2a (5-HT2a) receptor antagonist,CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2.Cl
NEFAZODONE HYDROCHLORIDE,CHEMBL1200492,Serotonin 2a (5-HT2a) receptor antagonist,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1.Cl
MESORIDAZINE BESYLATE,CHEMBL1201052,Serotonin 2a (5-HT2a) receptor antagonist,CN1CCCCC1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21.O=S(=O)(O)c1ccccc1
PALIPERIDONE PALMITATE,CHEMBL2107360,Serotonin 2a (5-HT2a) receptor antagonist,CCCCCCCCCCCCCCCC(=O)OC1CCCn2c1nc(C)c(CCN1CCC(c3noc4cc(F)ccc34)CC1)c2=O
QUETIAPINE FUMARATE,CHEMBL3188993,Serotonin 2a (5-HT2a) receptor antagonist,O=C(O)/C=C/C(=O)O.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1.OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
ILOPERIDONE,CHEMBL14376,Serotonin 2a (5-HT2a) receptor antagonist,COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1
THIOTHIXENE,CHEMBL1201,Serotonin 2a (5-HT2a) receptor antagonist,CN1CCN(CC/C=C2/c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1
TRIMIPRAMINE MALEATE,CHEMBL1200948,Serotonin 2a (5-HT2a) receptor antagonist,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21.O=C(O)/C=C\C(=O)O
HALOPERIDOL DECANOATE,CHEMBL1200986,Serotonin 2a (5-HT2a) receptor antagonist,CCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1
ZIPRASIDONE HYDROCHLORIDE,CHEMBL1375743,Serotonin 2a (5-HT2a) receptor antagonist,Cl.O.O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
BREXPIPRAZOLE,CHEMBL2105760,Serotonin 2a (5-HT2a) receptor antagonist,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1
ARIPIPRAZOLE LAUROXIL,CHEMBL2219425,Serotonin 2a (5-HT2a) receptor antagonist,CCCCCCCCCCCC(=O)OCN1C(=O)CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21
THIOTHIXENE HYDROCHLORIDE,CHEMBL3989824,Serotonin 2a (5-HT2a) receptor antagonist,CN1CCN(CC/C=C2/c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1.Cl.Cl.O.O
ZIPRASIDONE MESYLATE,CHEMBL3989833,Serotonin 2a (5-HT2a) receptor antagonist,CS(=O)(=O)O.O.O.O.O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
HALOPERIDOL LACTATE,CHEMBL4297147,Serotonin 2a (5-HT2a) receptor antagonist,CC(O)C(=O)O.O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
VOLINANSERIN,CHEMBL74355,Serotonin 2a (5-HT2a) receptor antagonist,COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC
EPLIVANSERIN,CHEMBL257704,Serotonin 2a (5-HT2a) receptor antagonist,CN(C)CCO/N=C(/C=C/c1ccc(O)cc1)c1ccccc1F
PRUVANSERIN,CHEMBL1215661,Serotonin 2a (5-HT2a) receptor antagonist,N#Cc1c[nH]c2c(C(=O)N3CCN(CCc4ccc(F)cc4)CC3)cccc12
TEDATIOXETINE,CHEMBL2104986,Serotonin 2a (5-HT2a) receptor antagonist,Cc1ccc(Sc2ccccc2C2CCNCC2)cc1
VABICASERIN HYDROCHLORIDE,CHEMBL2104991,Serotonin 2a (5-HT2a) receptor antagonist,Cl.c1cc2c3c(c1)[C@H]1CCC[C@H]1CN3CCNC2
ESMIRTAZAPINE MALEATE,CHEMBL2107339,Serotonin 2a (5-HT2a) receptor antagonist,CN1CCN2c3ncccc3Cc3ccccc3[C@H]2C1.O=C(O)/C=C\C(=O)O
TRELANSERIN,CHEMBL3183740,Serotonin 2a (5-HT2a) receptor antagonist,NC(=O)Cn1c(=O)cc(CCN2CCN(c3nccc4sccc34)CC2)c2ccc(F)cc21
LUMATEPERONE,CHEMBL3306803,Serotonin 2a (5-HT2a) receptor antagonist,CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12
IFERANSERIN,CHEMBL3989686,Serotonin 2a (5-HT2a) receptor antagonist,CN1CCCC[C@H]1CCc1ccccc1NC(=O)/C=C/c1ccccc1
SB-773812,CHEMBL5314394,Serotonin 2a (5-HT2a) receptor antagonist,COc1cc2c(cc1S(=O)(=O)c1ccc(OCc3ccc(Cl)cc3)cc1)CCN(C)CC2
CIMETIDINE,CHEMBL30,Histamine H2 receptor antagonist,CN/C(=N\CCSCc1nc[nH]c1C)NC#N
TRANEXAMIC ACID,CHEMBL877,Plasminogen inhibitor,NC[C@H]1CC[C@H](C(=O)O)CC1
FAMOTIDINE,CHEMBL902,Histamine H2 receptor antagonist,NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1
SARPOGRELATE,CHEMBL52939,Serotonin 2a (5-HT2a) receptor antagonist,COc1cccc(CCc2ccccc2OCC(CN(C)C)OC(=O)CCC(=O)O)c1
AMINOCAPROIC ACID,CHEMBL1046,Plasminogen inhibitor,NCCCCCC(=O)O
BLONANSERIN,CHEMBL178803,Serotonin 2a (5-HT2a) receptor antagonist,CCN1CCN(c2cc(-c3ccc(F)cc3)c3c(n2)CCCCCC3)CC1
CIMETIDINE HYDROCHLORIDE,CHEMBL1201051,Histamine H2 receptor antagonist,CN/C(=N\CCSCc1nc[nH]c1C)NC#N.Cl
RANITIDINE HYDROCHLORIDE,CHEMBL2110372,Histamine H2 receptor antagonist,CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1.Cl
RANITIDINE BISMUTH CITRATE,CHEMBL2111286,Histamine H2 receptor antagonist,CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1.O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Bi+3]
NIZATIDINE,CHEMBL3183075,Histamine H2 receptor antagonist,CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1
PENTOXIFYLLINE,CHEMBL628,"3',5'-cyclic phosphodiesterase inhibitor",CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O
DIPYRIDAMOLE,CHEMBL932,"3',5'-cyclic phosphodiesterase inhibitor | Equilibrative nucleoside transporter 1 inhibitor",OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1
LEFLUNOMIDE,CHEMBL960,Dihydroorotate dehydrogenase inhibitor,Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1
TERIFLUNOMIDE,CHEMBL973,Dihydroorotate dehydrogenase inhibitor,C/C(O)=C(\C#N)C(=O)Nc1ccc(C(F)(F)F)cc1
VIDOFLUDIMUS,CHEMBL197194,Dihydroorotate dehydrogenase inhibitor,COc1cccc(-c2ccc(NC(=O)C3=C(C(=O)O)CCC3)c(F)c2)c1
METHANTHELINE BROMIDE,CHEMBL1200988,Histamine H2 receptor antagonist,CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc2ccccc21.[Br-]
LAFUTIDINE,CHEMBL1742461,Histamine H2 receptor antagonist,O=C(C[S+]([O-])Cc1ccco1)NC/C=C\COc1cc(CN2CCCCC2)ccn1
EBROTIDINE,CHEMBL1742471,Histamine H2 receptor antagonist,NC(N)=Nc1nc(CSCCN/C=N/S(=O)(=O)c2ccc(Br)cc2)cs1
RANITIDINE,CHEMBL1790041,Histamine H2 receptor antagonist,CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1
ASLAN-003,CHEMBL2263632,Dihydroorotate dehydrogenase inhibitor,COc1cccc(-c2cc(F)c(Nc3ncccc3C(=O)O)c(F)c2)c1
BREQUINAR,CHEMBL38434,Dihydroorotate dehydrogenase inhibitor,Cc1c(-c2ccc(-c3ccccc3F)cc2)nc2ccc(F)cc2c1C(=O)O
DSM-265,CHEMBL1956285,Dihydroorotate dehydrogenase inhibitor,Cc1cc(Nc2ccc(S(F)(F)(F)(F)F)cc2)n2nc(C(C)(F)F)nc2n1
EMVODODSTAT,CHEMBL4650336,Dihydroorotate dehydrogenase inhibitor,COc1ccc([C@H]2c3[nH]c4ccc(Cl)cc4c3CCN2C(=O)Oc2ccc(Cl)cc2)cc1
